<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">61313</article-id><article-id pub-id-type="doi">10.7554/eLife.61313</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>The SWELL1-LRRC8 complex regulates endothelial AKT-eNOS signaling and vascular function</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-200614"><name><surname>Alghanem</surname><given-names>Ahmad F</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5823-3806</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">†</xref></contrib><contrib contrib-type="author" id="author-200610"><name><surname>Abello</surname><given-names>Javier</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189471"><name><surname>Maurer</surname><given-names>Joshua M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2107-0767</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189464"><name><surname>Kumar</surname><given-names>Ashutosh</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-200606"><name><surname>Ta</surname><given-names>Chau My</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189468"><name><surname>Gunasekar</surname><given-names>Susheel K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-200630"><name><surname>Fatima</surname><given-names>Urooj</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-200608"><name><surname>Kang</surname><given-names>Chen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189465"><name><surname>Xie</surname><given-names>Litao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-200609"><name><surname>Adeola</surname><given-names>Oluwaseun</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-200611"><name><surname>Riker</surname><given-names>Megan</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-200612"><name><surname>Elliot-Hudson</surname><given-names>Macaulay</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189469"><name><surname>Minerath</surname><given-names>Rachel A</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189472"><name><surname>Grueter</surname><given-names>Chad E</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-5192"><name><surname>Mullins</surname><given-names>Robert F</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182901"><name><surname>Stratman</surname><given-names>Amber N</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8111-4186</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-188020"><name><surname>Sah</surname><given-names>Rajan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1092-1244</contrib-id><email>rajan.sah@wustl.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Internal Medicine, Cardiovascular Division, Washington University School of Medicine</institution><addr-line><named-content content-type="city">St. Louis</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Eastern Region, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences</institution><addr-line><named-content content-type="city">Al Hasa</named-content></addr-line><country>Saudi Arabia</country></aff><aff id="aff3"><label>3</label><institution>Department of Cell Biology and Physiology, Washington University in St. Louis, School of Medicine</institution><addr-line><named-content content-type="city">St. Louis</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Department of Internal Medicine, Cardiovascular Division, University of Iowa</institution><addr-line><named-content content-type="city">Iowa City</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>Department of Ophthalmology, University of Iowa, Carver College of Medicine</institution><addr-line><named-content content-type="city">Iowa City</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>Center for Cardiovascular Research, Washington University</institution><addr-line><named-content content-type="city">St Louis</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Nelson</surname><given-names>Mark T</given-names></name><role>Reviewing Editor</role><aff><institution>University of Vermont</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Swartz</surname><given-names>Kenton J</given-names></name><role>Senior Editor</role><aff><institution>National Institute of Neurological Disorders and Stroke, National Institutes of Health</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Eastern Region, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Al Hasa, Saudi Arabia</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>25</day><month>02</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e61313</elocation-id><history><date date-type="received" iso-8601-date="2020-07-22"><day>22</day><month>07</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-02-22"><day>22</day><month>02</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Alghanem et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Alghanem et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-61313-v2.pdf"/><abstract><p>The endothelium responds to numerous chemical and mechanical factors in regulating vascular tone, blood pressure, and blood flow. The endothelial volume-regulated anion channel (VRAC) has been proposed to be mechanosensitive and thereby sense fluid flow and hydrostatic pressure to regulate vascular function. Here, we show that the leucine-rich repeat-containing protein 8a, LRRC8A (SWELL1), is required for VRAC in human umbilical vein endothelial cells (HUVECs). Endothelial LRRC8A regulates AKT-endothelial nitric oxide synthase (eNOS) signaling under basal, stretch, and shear-flow stimulation, forms a GRB2-Cav1-eNOS signaling complex, and is required for endothelial cell alignment to laminar shear flow. Endothelium-restricted <italic>Lrrc8a</italic> KO mice develop hypertension in response to chronic angiotensin-II infusion and exhibit impaired retinal blood flow with both diffuse and focal blood vessel narrowing in the setting of type 2 diabetes (T2D). These data demonstrate that LRRC8A regulates AKT-eNOS in endothelium and is required for maintaining vascular function, particularly in the setting of T2D.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>ion channel</kwd><kwd>mechanobiology</kwd><kwd>hypertension</kwd><kwd>diabetes</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01DK106009</award-id><principal-award-recipient><name><surname>Sah</surname><given-names>Rajan</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>5R00HL125683</award-id><principal-award-recipient><name><surname>Stratman</surname><given-names>Amber N</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>R01 HL125436</award-id><principal-award-recipient><name><surname>Grueter</surname><given-names>Chad E</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>R35 GM137976</award-id><principal-award-recipient><name><surname>Stratman</surname><given-names>Amber N</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>VA Merit Award</institution></institution-wrap></funding-source><award-id>I01BX005072</award-id><principal-award-recipient><name><surname>Sah</surname><given-names>Rajan</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution>Cancer Research Foundation</institution></institution-wrap></funding-source><award-id>Young Investigator Award</award-id><principal-award-recipient><name><surname>Stratman</surname><given-names>Amber N</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001024</institution-id><institution>Roy J. Carver Charitable Trust</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Sah</surname><given-names>Rajan</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution>UIHC Center</institution></institution-wrap></funding-source><award-id>I01B 005072</award-id><principal-award-recipient><name><surname>Sah</surname><given-names>Rajan</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>SWELL1 is required for basal, stretch, and flow-mediated endothelial AKT-eNOS signaling in vitro and protects against angiotensin-induced hypertension and diabetes-associated vascular dysfunction in vivo.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The endothelium integrates mechanical and chemical stimuli to regulate vascular tone, angiogenesis, blood flow, and blood pressure (<xref ref-type="bibr" rid="bib10">Cahill and Redmond, 2016</xref>). Endothelial cells express a variety of mechanosensitive and mechanoresponsive ion channels that regulate vascular function (<xref ref-type="bibr" rid="bib24">Gerhold and Schwartz, 2016</xref>), including TRPV4 (<xref ref-type="bibr" rid="bib75">Sonkusare et al., 2012</xref>; <xref ref-type="bibr" rid="bib20">Earley et al., 2009</xref>; <xref ref-type="bibr" rid="bib93">Zhang et al., 2009</xref>; <xref ref-type="bibr" rid="bib48">Mendoza et al., 2010</xref>) and Piezo1 (<xref ref-type="bibr" rid="bib63">Rode et al., 2017</xref>; <xref ref-type="bibr" rid="bib45">Li et al., 2014</xref>; <xref ref-type="bibr" rid="bib13">Coste et al., 2010</xref>). The volume-regulated anion channel (VRAC) current is also prominent in endothelium and has been proposed to be mechanoresponsive (<xref ref-type="bibr" rid="bib56">Nilius and Droogmans, 2001</xref>), to activate in response to fluid flow/hydrostatic pressure (<xref ref-type="bibr" rid="bib4">Barakat et al., 1999</xref>) and to putatively regulate vascular reactivity. However, the molecular identity of this endothelial ion channel has remained a mystery for nearly two decades.</p><p><italic>Lrrc8a</italic> (leucine-rich repeat-containing protein 8A, also known as SWELL1) encodes a transmembrane protein first described as the site of a balanced translocation in an immunodeficient child with agammaglobulinemia and absent B-cells (<xref ref-type="bibr" rid="bib66">Sawada et al., 2003</xref>; <xref ref-type="bibr" rid="bib42">Kubota et al., 2004</xref>). Subsequent work revealed the mechanism for this condition to be due to impaired LRRC8A-dependent GRB2-PI3K-AKT signaling in lymphocytes, resulting in a developmental block in lymphocyte differentiation (<xref ref-type="bibr" rid="bib43">Kumar et al., 2014</xref>). Thus, for ~11 years, LRRC8A was conceived of as a membrane protein that regulates PI3K-AKT mediated lymphocyte function (<xref ref-type="bibr" rid="bib66">Sawada et al., 2003</xref>; <xref ref-type="bibr" rid="bib42">Kubota et al., 2004</xref>). Although LRRC8A had been predicted to form a hetero-hexameric ion channel complex with other LRRC8 family members (<xref ref-type="bibr" rid="bib1">Abascal and Zardoya, 2012</xref>), it was not until 2014 that LRRC8A was shown to form an essential component of the volume-regulated anion channel (VRAC) (<xref ref-type="bibr" rid="bib59">Qiu et al., 2014</xref>; <xref ref-type="bibr" rid="bib84">Voss et al., 2014</xref>), forming hetero-hexamers with LRRC8b-e (<xref ref-type="bibr" rid="bib84">Voss et al., 2014</xref>; <xref ref-type="bibr" rid="bib79">Syeda et al., 2016</xref>). Therefore, historically, LRRC8A was first described as a membrane protein that signaled via protein-protein interactions and then later found to form an ion channel signaling complex.</p><p>We showed previously that LRRC8A is an essential component of VRAC in adipocytes (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>) and skeletal myotubes (<xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>), which is required for insulin-PI3K-AKT signaling (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>; <xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>) to mediate adipocyte hypertrophy (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>), skeletal myotube differentiation (<xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>), skeletal muscle function (<xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>), and systemic glucose homeostasis (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>; <xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>; <xref ref-type="bibr" rid="bib90">Xie et al., 2017</xref>; <xref ref-type="bibr" rid="bib28">Gunasekar et al., 2019</xref>). The PI3K-AKT-endothelial nitric oxide synthase (eNOS) signaling pathway is central to transducing both mechanical stretch (<xref ref-type="bibr" rid="bib32">Hu et al., 2013</xref>) and hormonal inputs (insulin) to regulate eNOS expression and activity, which, in turn, regulates vasodilation (blood flow and pressure), inhibits leukocyte aggregation, and limits proliferation of vascular smooth muscle cells (atherosclerosis). Indeed, insulin resistance is thought to be a systemic disorder in the setting of type 2 diabetes (T2D), affecting endothelium in addition to traditional metabolically important tissues, such as adipose, liver, and skeletal muscle (<xref ref-type="bibr" rid="bib33">Janus et al., 2016</xref>; <xref ref-type="bibr" rid="bib38">Kearney et al., 2008</xref>; <xref ref-type="bibr" rid="bib52">Muniyappa and Sowers, 2013</xref>). In fact, insulin-resistant endothelium and the resultant impairment in PI3K-AKT-eNOS signaling have been proposed to underlie much of the endothelial dysfunction observed in the setting of obesity and T2D, predisposing to hypertension, atherosclerosis, and vascular disease (<xref ref-type="bibr" rid="bib33">Janus et al., 2016</xref>; <xref ref-type="bibr" rid="bib38">Kearney et al., 2008</xref>; <xref ref-type="bibr" rid="bib52">Muniyappa and Sowers, 2013</xref>).</p><p>In this study, we demonstrate that VRAC is LRRC8A-dependent in endothelium, associates with GRB2, caveolin-1 (Cav1), eNOS, and regulates PI3K-AKT-eNOS signaling and flow-mediated endothelial cell orientation – suggesting that LRRC8 channel complexes link insulin and mechano-signaling in endothelium. LRRC8A-dependent AKT-eNOS, ERK1/2, and mTOR signaling influences blood pressure and vascular function in vivo, while impaired endothelial LRRC8A signaling predisposes to vascular dysfunction in the setting of diet-induced T2D.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>Lrrc8a</italic> functionally encodes VRAC current in endothelium</title><p>The volume-regulatory anion channel (VRAC) current has been measured and characterized in endothelial cells for decades but the molecular identity of this endothelial ion channel remains elusive (<xref ref-type="bibr" rid="bib56">Nilius and Droogmans, 2001</xref>; <xref ref-type="bibr" rid="bib4">Barakat et al., 1999</xref>; <xref ref-type="bibr" rid="bib5">Barakat, 1999</xref>). To determine if the leucine-rich repeat-containing membrane protein LRRC8A recently identified in cell lines (<xref ref-type="bibr" rid="bib59">Qiu et al., 2014</xref>; <xref ref-type="bibr" rid="bib84">Voss et al., 2014</xref>) is required for VRAC in endothelial cells, as it is in adipocytes (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>), skeletal myoblasts (<xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>) pancreatic ß-cells (<xref ref-type="bibr" rid="bib36">Kang et al., 2018</xref>; <xref ref-type="bibr" rid="bib78">Stuhlmann et al., 2018</xref>), nodose neurons (<xref ref-type="bibr" rid="bib85">Wang et al., 2017</xref>), and spermatozoa (<xref ref-type="bibr" rid="bib47">Lück et al., 2018</xref>), we first confirmed robust LRRC8A protein expression by Western blot (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) and immunostaining (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) in human umbilical vein endothelial cells (HUVECs). LRRC8A protein expression is substantially reduced upon adenoviral transduction with a short-hairpin RNA directed to <italic>Lrrc8a</italic> (Ad-sh<italic>Lrrc8a</italic>-mCherry) as compared to a scrambled control (Ad-sh<italic>Scr</italic>-mCherry). Next, we measured hypotonically induced (210 mOsm) endothelial VRAC currents in HUVECs. These classic outwardly rectifying hypotonically induced VRAC currents are prominent in HUVECs, largely blocked by the VRAC current inhibitor 4-(2-butyl-6,7-dichloro-2-cyclopentyl-indan-1-on-5-yl) oxobutyric acid (DCPIB; <xref ref-type="fig" rid="fig1">Figure 1C&amp;D</xref>), and significantly suppressed upon sh<italic>Lrrc8a</italic>-mediated LRRC8A knock-down (KD) (<xref ref-type="fig" rid="fig1">Figure 1E&amp;F</xref>), consistent with LRRC8A functionally encoding endothelial VRAC.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Leucine-rich repeat-containing protein 8a (LRRC8A) mediates volume-regulated anion channel (VRAC) currents in human umbilical vein endothelial cells (HUVECs).</title><p>(<bold>A</bold>) LRRC8A Western blot in HUVECs transduced with adenovirus expressing a short-hairpin RNA directed to LRRC8A (Ad-sh<italic>Lrrc8a</italic>) compared to control scrambled short-hairpin RNA (Ad-sh<italic>Scr</italic>). GAPDH is used as loading control. (<bold>B</bold>) Immunofluorescence staining of the HUVECs transduced with Ad-sh<italic>Lrrc8a</italic> and Ad-sh<italic>Scr</italic>. (<bold>C</bold>) Current-time relationship of VRAC current (hypotonic, 210 mOsm) in Ad-sh<italic>Scr</italic> transduced HUVEC and co-application of 10 µM 4-(2-butyl-6,7-dichloro-2-cyclopentyl-indan-1-on-5-yl) oxobutyric acid (DCPIB). (<bold>D</bold>) Representative current traces upon hypotonic activation (left) during voltage steps (from -100 to +100 mV, shown in inset) and inhibition by DCPIB (right). (<bold>E</bold>) Current-voltage relationship of VRAC during voltage ramps from -100 mV to +100 mV after hypotonic swelling in HUVECs transduced with Ad-sh<italic>Scr</italic> and Ad-sh<italic>Lrrc8a</italic>. (<bold>F</bold>) Mean current outward and inward densities at +100 and -100 mV (n,<sub>shSCR</sub>=4 cells; n,<sub>shLrrc8a</sub>=6 cells). Data are shown as mean ± s.e.m. *p&lt;0.05; **p&lt;0.01; unpaired t-test for (<bold>F</bold>).</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1">Figure 1F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61313-fig1-v2.tif"/></fig></sec><sec id="s2-2"><title>LRRC8A regulates PI3K-AKT-eNOS, ERK, and mTOR signaling in endothelium</title><p>Previous studies in adipocytes (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>) and skeletal muscle (<xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>) demonstrate that LRRC8A regulates insulin-PI3K-AKT signaling (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>; <xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>), adipocyte expansion (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>), skeletal muscle function (<xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>), and systemic glycemia, whereby LRRC8A loss-of-function induces an insulin-resistant pre-diabetic state (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>; <xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>; <xref ref-type="bibr" rid="bib90">Xie et al., 2017</xref>). Insulin signaling is also important in regulating endothelium and vascular function (<xref ref-type="bibr" rid="bib38">Kearney et al., 2008</xref>; <xref ref-type="bibr" rid="bib52">Muniyappa and Sowers, 2013</xref>; <xref ref-type="bibr" rid="bib17">Duncan et al., 2008</xref>). Moreover, insulin resistance in T2D is considered a systemic disorder and insulin-resistant endothelium is postulated to underlie impaired vascular function in T2D (<xref ref-type="bibr" rid="bib38">Kearney et al., 2008</xref>; <xref ref-type="bibr" rid="bib52">Muniyappa and Sowers, 2013</xref>). As LRRC8A is highly expressed in endothelium (<xref ref-type="fig" rid="fig1">Figure 1</xref>) and PI3K-AKT-eNOS signaling is critical for endothelium-dependent vascular function (<xref ref-type="bibr" rid="bib51">Morello et al., 2009</xref>), we next examined AKT-eNOS, ERK1/2, and mTOR signaling in LRRC8A KD compared to control HUVECs under basal conditions. Basal phosphorylated AKT2 (pAKT2, <xref ref-type="fig" rid="fig2">Figure 2A&amp;D</xref>), pAKT1 (<xref ref-type="fig" rid="fig2">Figure 2A&amp;E</xref>), phosphorylated eNOS (p-eNOS) (<xref ref-type="fig" rid="fig2">Figure 2A&amp;C</xref>), and pERK1/2 (<xref ref-type="fig" rid="fig2">Figure 2A&amp;F</xref>) are abrogated in HUVECs upon LRRC8A KD, indicating that LRRC8A contributes to AKT-eNOS and ERK signaling in endothelium. Curiously, basal pS6 ribosomal protein, indicative of mTOR signaling, is augmented in LRRC8A KD HUVECs compared to control (<xref ref-type="fig" rid="fig2">Figure 2A&amp;G</xref>), suggesting LRRC8A to be a negative regulator of mTOR in endothelium. As a complementary approach, we used siRNA mediated LRRC8A KD using a silencer select siRNA targeting <italic>Lrrc8a</italic> mRNA with a different sequence from sh<italic>Lrrc8a</italic>. siRNA mediated LRRC8A KD in HUVECs yielded nearly identical results to the shRNA KD approach (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). In summary, LRRC8A expression level regulates AKT, eNOS, ERK, and mTOR signaling in endothelium.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Leucine-rich repeat-containing protein 8a (LRRC8A) regulates PI3K-AKT-endothelial nitric oxide synthase (eNOS), ERK signaling in endothelium.</title><p>(<bold>A</bold>) Western blots of LRRC8A, pAkt2, pAkt1, Akt2, Akt1, pErk1/2, Erk1/2, phosphorylated eNOS (p-eNOS), eNOS, pS6K ribosomal protein, S6K ribosomal protein, GAPDH, and ß-actin in Ad-sh<italic>Scr</italic> and Ad-sh<italic>Lrrc8a</italic> transduced human umbilical vein endothelial cells (HUVECs) under basal conditions. Quantification of LRRC8A/ß-actin (<bold>B</bold>), p-eNOS/ß-actin, p-eNOS/total eNOS (<bold>C</bold>), pAkt2/ß-actin, pAkt2/total Akt2 (<bold>D</bold>), pAkt1/GAPDH, pAkt1/total Akt1 (<bold>E</bold>), pERK1/2/GAPDH, pErk1/2/total Erk1/2 (<bold>F</bold>), pS6 ribosomal protein/GAPDH, and pS6K ribosomal protein/total S6K ribosomal protein (<bold>G</bold>). N = 6 independent experiments. Significance between the indicated groups in all blots was calculated using a two-tailed unpaired Student’s t-test. Data are shown as mean ± s.e.m. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61313-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Leucine-rich repeat-containing protein 8a (LRRC8A) regulates PI3K-AKT-endothelial nitric oxide synthase (eNOS) and ERK signaling in endothelium.</title><p>(<bold>A</bold>) Western blots of LRRC8A, pAkt2, pAkt1, Akt, pErk1/2, Erk1/2, phosphorylated eNOS (p-eNOS), eNOS, pS6K ribosomal protein, S6K ribosomal protein, and ß-actin in si-SCR and si-LRRC8A transfected human umbilical vein endothelial cells (HUVECs) under basal conditions. Quantification of LRRC8A/ß-actin (<bold>B</bold>), p-eNOS/ß-actin, p-eNOS/total eNOS (<bold>C</bold>), pAkt2/ß-actin, pAkt2/total Akt (<bold>D</bold>), pAkt1/ß-actin, pAkt1/total Akt (<bold>E</bold>), pERK1/2 /ß-actin, pErk1/2/total Erk1/2 (<bold>F</bold>), pS6 ribosomal protein/ß-actin, and pS6K ribosomal protein/total S6K ribosomal protein (<bold>G</bold>). N = 6 independent experiments. Significance between the indicated groups in all blots was calculated using a two-tailed Student’s t-test. Error bars represent mean ± s.e.m. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig2-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61313-fig2-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>LRRC8A interacts with GRB2, Cav1, and eNOS and mediates stretch-dependent eNOS signaling</title><p>In adipocytes, the mechanism of LRRC8A-mediated regulation of PI3K-AKT signaling involves LRRC8A/GRB2/Cav1 molecular interactions (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>). To determine if LRRC8A resides in a similar macromolecular signaling complex in endothelium, we immunoprecipitated (IP) endogenous GRB2 from HUVECs. Upon GRB2 IP, we detected LRRC8A protein in sh<italic>Scr-</italic>treated HUVECs and less LRRC8A upon GRB2 IP from sh<italic>Lrrc8a</italic>-treated HUVECs, consistent with an LRRC8A-GRB2 interaction (<xref ref-type="fig" rid="fig3">Figure 3A&amp;B</xref>). In addition, with GRB2 IP, we also detected both Cav1 (<xref ref-type="fig" rid="fig3">Figure 3A&amp;B</xref>) and eNOS (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). These data suggest that endothelial LRRC8A resides in a signaling complex that includes GRB2, Cav1, and eNOS, consistent with the findings that GRB2 and Cav1 interact, and that Cav1 regulates eNOS via a direct interaction (<xref ref-type="bibr" rid="bib34">Ju et al., 1997</xref>; <xref ref-type="bibr" rid="bib83">Venema et al., 1997</xref>; <xref ref-type="bibr" rid="bib27">Goligorsky et al., 2002</xref>). Also, GRB2 has been shown to regulate endothelial ERK, AKT, and JNK signaling (<xref ref-type="bibr" rid="bib65">Salameh et al., 2005</xref>). Moreover, these data are also in line with the notion that caveoli form mechanosensitive microdomains (<xref ref-type="bibr" rid="bib55">Nassoy and Lamaze, 2012</xref>; <xref ref-type="bibr" rid="bib74">Sinha et al., 2011</xref>; <xref ref-type="bibr" rid="bib71">Sedding et al., 2005</xref>) which regulate VRAC (<xref ref-type="bibr" rid="bib82">Trouet et al., 2001</xref>; <xref ref-type="bibr" rid="bib81">Trouet et al., 1999</xref>; <xref ref-type="bibr" rid="bib21">Egorov et al., 2019</xref>), and VRAC can be activated by mechanical stimuli in a number of cell types, including endothelium (<xref ref-type="bibr" rid="bib56">Nilius and Droogmans, 2001</xref>; <xref ref-type="bibr" rid="bib5">Barakat, 1999</xref>; <xref ref-type="bibr" rid="bib7">Browe and Baumgarten, 2003</xref>; <xref ref-type="bibr" rid="bib8">Browe and Baumgarten, 2006</xref>; <xref ref-type="bibr" rid="bib54">Nakao et al., 1999</xref>; <xref ref-type="bibr" rid="bib64">Romanenko et al., 2002</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Leucine-rich repeat-containing protein 8A (LRRC8A) interacts with Grb2, Cav1, and endothelial nitric oxide synthase (eNOS) in human endothelium.</title><p>(<bold>A</bold>) GRB2 immunoprecipitation from Ad-sh<italic>Scr</italic> and Ad-sh<italic>Lrrc8a</italic> transduced human umbilical vein endothelial cells (HUVECs) and immunoblot with LRRC8A, Cav1, and GRB2 antibodies. Densitometry values for GRB2 co-immunoprecipitated LRRC8A (LRRC8A/GRB2) and GRB2 co-immunoprecipitated Cav1 (Cav1/GRB2). GAPDH serves as loading control for input samples. (<bold>B</bold>) GRB2 immunoprecipitation from Ad-sh<italic>Scr</italic> and Ad-sh<italic>Lrrc8a</italic> transduced HUVECs and immunoblot with LRRC8A, eNOS, Cav1, and GRB2 antibodies. Insulin stimulation: 100 nM insulin for 10 min. Densitometry values for GRB2 co-immunoprecipitated eNOS (eNOS/GRB2). Representative blots from three independent experiments. (<bold>C</bold>) Representative endogenous LRRC8A and eNOS immunofluorescence staining in Ad-sh<italic>Scr</italic> and Ad-sh<italic>Lrrc8a</italic> transduced HUVECs. Representative image from six independent experiments. (<bold>D–E</bold>) Quantification of LRRC8A (<bold>D</bold>, n = 6) and eNOS (<bold>E</bold>, n = 6) immunofluorescence staining upon LRRC8A knock-down (KD). Evidence of LRRC8A-eNOS co-localization (C, insets) in plasma membrane (<bold>i</bold>) and perinuclear regions (<bold>ii</bold>). Significance between the indicated groups is calculated using an unpaired two-tailed Student’s t-test. p-Values are indicated on figures. Data are shown as mean ± s.e.m. ***p&lt;0.001.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3">Figure 3D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig3-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3">Figure 3E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig3-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61313-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Leucine-rich repeat-containing protein 8a (LRRC8A) co-localizes with endothelial nitric oxide synthase (eNOS) and regulates eNOS expression.</title><p>LRRC8A (green) and eNOS (red) immunofluorescence staining of human umbilical vein endothelial cell (HUVEC) transduced with either Ad-sh<italic>Scr</italic> (left) or Ad-sh<italic>Lrrc8a</italic> (right). Scale bar is 20 µm. DAPI (blue) labels nuclei.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61313-fig3-figsupp1-v2.tif"/></fig></fig-group><p>We also examined the relationship between LRRC8A and eNOS protein expression and localization in HUVECs by immunofluorescence (IF) staining (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Similar to observed by Western blot (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), IF staining revealed that reductions in LRRC8A expression correlate with reduced eNOS expression (<xref ref-type="fig" rid="fig3">Figure 3C–E</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Moreover, LRRC8A and eNOS co-localization in plasma membrane and perinuclear intracellular domains (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, inset) were consistent with the IP data, revealing an LRRC8A-GRB2-Cav-eNOS interaction (<xref ref-type="fig" rid="fig3">Figure 3A&amp;B</xref>), and also with the previously described intracellular eNOS localization (<xref ref-type="bibr" rid="bib23">Fulton et al., 2002</xref>).</p><p>Given that endothelial cells respond to stretch stimuli to regulate vascular tone via activation of eNOS (<xref ref-type="bibr" rid="bib35">Jufri et al., 2015</xref>), we next examined the LRRC8A dependence of stretch-induced AKT, ERK1/2, and eNOS signaling in HUVECs (<xref ref-type="fig" rid="fig4">Figure 4</xref>), similar to several previous studies (<xref ref-type="bibr" rid="bib31">Hsu et al., 2010</xref>; <xref ref-type="bibr" rid="bib72">Shi et al., 2007</xref>; <xref ref-type="bibr" rid="bib46">Liu et al., 2003</xref>; <xref ref-type="bibr" rid="bib26">Goettsch et al., 2009</xref>). Stretch (5%) was sufficient to stimulate AKT1 and AKT2 signaling (<xref ref-type="fig" rid="fig4">Figure 4A–C</xref>), though not ERK1/2 signaling (<xref ref-type="fig" rid="fig4">Figure 4D</xref>) in HUVECs, and all were blunted in LRRC8A KD HUVECS (<xref ref-type="fig" rid="fig4">Figure 4A–D</xref>). Similarly, we observed abrogation of time-dependent p-eNOS signaling with 5% stretch in LRRC8A KD HUVECs compared to control (<xref ref-type="fig" rid="fig4">Figure 4E&amp;F</xref>). Taken together, these data position LRRC8A as a regulator stretch-mediated PI3K-AKT-eNOS signaling in endothelium.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Leucine-rich repeat-containing protein 8a (LRRC8A) is required for intact stretch-induced AKT-endothelial nitric oxide synthase (eNOS) signaling.</title><p>(<bold>A</bold>) Western blot of LRRC8A, pAKT1, pAKT2, pERK1/2 in response to 30 min of 0.1% and 5% static stretch in Ad-sh<italic>Scr</italic> (n = 3) and Ad-sh<italic>Lrrc8a</italic> (n = 3) transduced human umbilical vein endothelial cells (HUVECs). GAPDH is used as a loading control. (<bold>B–D</bold>) Densitometry quantification from A of pAKT1 (<bold>B</bold>), pAKT2 (<bold>C</bold>), and pErk1/2 (<bold>D</bold>). (<bold>E</bold>) Western blot of peNOS, LRRC8A, in response to 5% static stretching for 5, 60, and 180 min in Ad-sh<italic>Scr</italic> (n = 3) and Ad-sh<italic>Lrrc8a</italic> (n = 3) transduced HUVECs. (<bold>F</bold>) Densitometry quantification from E of eNOS. GAPDH is used as a loading control. Statistical significance between the indicated group is calculated using one-way analysis of variance (ANOVA), Tukey's multiple comparisons test for (<bold>B–D</bold>), and two-way ANOVA for (<bold>F</bold>) with p-value in upper left corner. Data are shown as mean ± s.e.m. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4">Figure 4F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig4-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4">Figure 4B,C, D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig4-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61313-fig4-v2.tif"/></fig></sec><sec id="s2-4"><title>Endothelial cell orientation to the direction of shear flow is impaired upon LRRC8A KD</title><p>To evaluate the requirement of LRRC8A for endothelial cell responses to physiological mechanical stimuli relevant to endothelium, we examined the LRRC8A dependence of HUVEC orientation to laminar shear flow. In response to laminar shear flow at 15 dynes/cm<sup>2</sup> for 24 hr (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), siControl transfected HUVECs oriented well to the direction of flow (<xref ref-type="fig" rid="fig5">Figure 5B–F</xref> and <xref ref-type="video" rid="fig5video1">Figure 5—videos 1</xref> and <xref ref-type="video" rid="fig5video2">2</xref>), while LRRC8A KD HUVEC exhibited impaired flow-mediated alignment (<xref ref-type="fig" rid="fig5">Figure 5B–F</xref> and <xref ref-type="video" rid="fig5video3">Figure 5—videos 3</xref> and <xref ref-type="video" rid="fig5video4">4</xref>). These LRRC8A-dependent differences were also apparent in the degree of impairment of HUVEC elongation to the direction of fluid flow (<xref ref-type="fig" rid="fig5">Figure 5G</xref>) and in the velocity of movement against the direction of flow (<xref ref-type="fig" rid="fig5">Figure 5H&amp;I</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Leucine-rich repeat-containing protein 8a (LRRC8A) depletion impairs human umbilical vein endothelial cell (HUVEC) alignment to the direction of shear flow.</title><p>(<bold>A</bold>) Cartoon of depicting the laminar shear flow applied to HUVEC at 15 dyne/cm<sup>2</sup> for 0, 2, and 24 hr. (<bold>B</bold>) Bright field image of HUVECs transfected with si<italic>Scr</italic> (top) and si<italic>Lrrc8a</italic> (bottom) with no flow (left) and after 24 hr of flow (right). (<bold>C</bold>) Distributions of angle of HUVEC orientation relative to the direction of flow at 0 hr and after 24 hr of laminar shear flow in si<italic>Scr-</italic>treated cells (top, 0 hr: n = 800; 24 hr: n = 800) and si<italic>Lrrc8a</italic> treated cells (bottom, 0 hr: n = 600; 24 hr: 800). Cuboidal or symmetrical cells at 0 hr were measured as 90<sup>o</sup> to the direction of flow. (<bold>D</bold>) Distributions of angle of HUVEC orientation relative to the direction of flow at 24 hr si<italic>Scr</italic> (black, n = 803) and si<italic>Lrrc8a</italic> treated cells (red, n = 803). (<bold>E</bold>) Mean alignment to direction of flow of si<italic>Scr</italic> (black, n = 803) and si<italic>Lrrc8a</italic> treated cells (red, n = 803). (<bold>F</bold>) Mean time required for HUVEC to align to within 20<sup>o</sup> of the direction of shear flow in si<italic>Scr</italic> (black, n = 110) and si<italic>Lrrc8a</italic> treated cells (red, n = 110). (<bold>G</bold>) Mean HUVEC length-width ratio over time upon stimulation with shear flow in si<italic>Scr</italic> (black, n = 157) and si<italic>Lrrc8a</italic> treated cells (red, n = 157). (<bold>H</bold>) Representative HUVEC real-time cell tracking during the 24 hr period of shear flow. Arrow heads represent the direction of travel against the direction of shear flow. (<bold>I</bold>) Average velocity calculated from the mean distance traveled over the 24 hr period of shear flow (n<sub>siScr</sub> = 77; n<sub>si<italic>Lrrc8a</italic></sub> = 78). (<bold>J</bold>) Representative phosphorylated endothelial nitric oxide synthase (p-eNOS) immunofluoresence (green) under conditions of no flow (n = 100), 2 hr (n = 100, top) and no flow (n = 110), 24 hr flow (n = 110, bottom). (<bold>K–L</bold>) Quantification of non-nuclear p-eNOS immunofluoresence (<bold>K</bold>) and whole-cell p-eNOS (<bold>L</bold>) under conditions of no flow (n = 100) and 2 hr flow (n = 100). (<bold>M–N</bold>) Quantification of non-nuclear p-eNOS immunofluoresence (<bold>M</bold>) and whole-cell p-eNOS (<bold>N</bold>) under conditions of no flow (n = 110) and 24 hr flow (n = 110). Statistical significance between the indicated values is calculated using a two-tailed Student’s t-test for (<bold>E</bold>), (<bold>F</bold>), and (<bold>I</bold>), using one-way analysis of variance (ANOVA), Tukey's multiple comparisons test for (<bold>K</bold>), (<bold>L</bold>), (<bold>M</bold>), and (<bold>N</bold>), and using two-way ANOVA with Bonferroni multiple comparison test in (<bold>G</bold>). In (<bold>G</bold>), p&lt;0.001 for the time dependence of si<italic>Scr</italic> versus si<italic>Lrrc8a</italic> treated cells, and p&lt;0.001 for the 24 hr timepoint. Error bars represent mean ± s.e.m. n = 3, independent experiments. **p&lt;0.01 and ***p&lt;0.001.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig5-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig5-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata3"><label>Figure 5—source data 3.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5G</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig5-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata4"><label>Figure 5—source data 4.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5I</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig5-data4-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata5"><label>Figure 5—source data 5.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5K</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig5-data5-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata6"><label>Figure 5—source data 6.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5L</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig5-data6-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata7"><label>Figure 5—source data 7.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5M</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig5-data7-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata8"><label>Figure 5—source data 8.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5N</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig5-data8-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61313-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Leucine-rich repeat-containing protein 8a (LRRC8A) knock-down abrogates shear-flow stimulated phosphorylated endothelial nitric oxide synthase (p-eNOS) in human umbilical vein endothelial cells (HUVECs).</title><p>(<bold>A</bold>) Representative p-eNOS immunofluorescence image of si<italic>Scr</italic> and si<italic>Lrrc8a</italic> transfected HUVEC after 24 hr of shear-flow stimulation, using anti-p-eNOS antibody (Cat#9571, from Cell Signaling). (<bold>B-C</bold>) Quantification of p-eNOS immunofluorescence intensity from non-nuclear regions (<bold>B</bold>) and from the entire cell (<bold>C</bold>). Significance between the indicated groups was calculated using a two-tailed Student’s t-test. Error bars represent mean ± s.e.m. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig5-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata2"><label>Figure 5—figure supplement 1—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig5-figsupp1-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61313-fig5-figsupp1-v2.tif"/></fig><media id="fig5video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-61313-fig5-video1.mp4"><label>Figure 5—video 1.</label><caption><title>Bright field time-lapse video of si<italic>Scr</italic> transfected human umbilical vein endothelial cell (HUVEC) responding to shear flow (direction of flow from left to right) over a 24 hr period.</title></caption></media><media id="fig5video2" mime-subtype="mp4" mimetype="video" xlink:href="elife-61313-fig5-video2.mp4"><label>Figure 5—video 2.</label><caption><title>Bright field time-lapse video of si<italic>Scr</italic> transfected human umbilical vein endothelial cell (HUVEC) responding to shear flow (direction of flow from left to right) over a 24 hr period.</title></caption></media><media id="fig5video3" mime-subtype="mp4" mimetype="video" xlink:href="elife-61313-fig5-video3.mp4"><label>Figure 5—video 3.</label><caption><title>Bright field time-lapse video of si<italic>Lrrc8a</italic> transfected human umbilical vein endothelial cell (HUVEC) responding to shear flow (direction of flow from left to right) over a 24 hr period.</title></caption></media><media id="fig5video4" mime-subtype="mp4" mimetype="video" xlink:href="elife-61313-fig5-video4.mp4"><label>Figure 5—video 4.</label><caption><title>Bright field time-lapse video of si<italic>Lrrc8a</italic> transfected human umbilical vein endothelial cell (HUVEC) responding to shear flow (direction of flow from left to right) over a 24 hr period.</title></caption></media></fig-group><p>Next, we asked whether shear-flow-mediated eNOS phosphorylation is LRRC8A-dependent, as observed with stretch-mediated signaling (<xref ref-type="fig" rid="fig4">Figure 4</xref>). We stimulated si<italic>Scr</italic> and si<italic>Lrrc8a</italic> transfected HUVECs with either no flow, or laminar shear flow for 2 or 24 hr and then immunostained for p-eNOS (<xref ref-type="fig" rid="fig5">Figure 5J</xref>). We observed marked p-eNOS induction in response to shear flow after both 2 and 24 hr in siControl transfected HUVECs, and this was significantly abrogated upon LRRC8A KD (<xref ref-type="fig" rid="fig5">Figure 5J</xref>). Interestingly, this shear-flow stimulated p-eNOS displayed significant nuclear localization, consistent with prior reports (<xref ref-type="bibr" rid="bib22">Feng et al., 1999</xref>; <xref ref-type="bibr" rid="bib2">Andersson and Brittebo, 2012</xref>; <xref ref-type="bibr" rid="bib86">Wang et al., 2019</xref>; <xref ref-type="bibr" rid="bib25">Gobeil et al., 2006</xref>). The same nuclear distribution was also observed using a different p-eNOS antibody (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). We quantified the intensity of p-eNOS staining in two ways: p-eNOS excluding the nuclear signal (<xref ref-type="fig" rid="fig5">Figure 5K,L</xref>) and p-eNOS in the entire cell (<xref ref-type="fig" rid="fig5">Figure 5M,O</xref>). In both cases, we observed significant shear-flow-mediated p-eNOS induction in si<italic>Scr</italic> HUVECs, after both 2 hr and 24 hr flow, and this was reduced in LRRC8A KD HUVEC (<xref ref-type="fig" rid="fig5">Figure 5K–O</xref>), consistent with LRRC8A-dependent flow-mediated p-eNOS signaling.</p></sec><sec id="s2-5"><title>Genome-wide mRNA profiling reveals LRRC8A-dependent regulation of multiple processes involved in angiogenesis, atherosclerosis, and vascular function</title><p>Genome-wide transcriptome analysis of LRRC8A KD HUVEC compared to control (RNA sequencing) revealed multiple pathways enriched regulating angiogenesis, migration, and tumorigenesis, including GADD45, IL-8, p70S6K (mTOR), TREM1, angiopoietin, and HGF signaling (<xref ref-type="fig" rid="fig6">Figure 6</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> and <xref ref-type="supplementary-material" rid="supp2">2</xref>). Pathways linked to cell adhesion and renin-angiotensin signaling are also enriched – both pathways and processes that are known to be altered in vasculature in the setting of atherosclerosis and T2D. Also, notable are statistically significant increases in VEGFA (1.6-fold) and CD31 (2.0-fold) expression in LRRC8A KD HUVECs (<xref ref-type="fig" rid="fig6">Figure 6C</xref>), both of which are pro-angiogenic and associated with mTORC1 hyperactivation (<xref ref-type="bibr" rid="bib16">Ding et al., 2018</xref>). CD36 is increased 3.4-fold and is also pro-angiogenic (<xref ref-type="bibr" rid="bib73">Silverstein and Febbraio, 2009</xref>) and pro-atherosclerotic (<xref ref-type="bibr" rid="bib58">Park, 2014</xref>; <xref ref-type="bibr" rid="bib29">Harb et al., 2009</xref>; <xref ref-type="bibr" rid="bib39">Kennedy et al., 2009</xref>). Moreover, the trends toward reduced eNOS protein expression observed upon LRRC8A KD in HUVECs (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, <xref ref-type="fig" rid="fig3">Figure 3C&amp;E</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) are also associated with twofold reduced eNOS mRNA expression (NOS3, <xref ref-type="fig" rid="fig6">Figure 6C</xref>). Notably, <italic>Lrrc8a</italic> mRNA expression in HUVECs is higher than many classical endothelial markers expressed in endothelium (EPOR, CDH5, CD36, VWF, PECAM1, KDR, VEGFA, <xref ref-type="fig" rid="fig6">Figure 6C</xref>). HUVEC <italic>Lrrc8a</italic> mRNA expression is also 2.5-fold higher than Piezo1 (<xref ref-type="fig" rid="fig6">Figure 6C</xref>), a mechanosensitive ion channel (<xref ref-type="bibr" rid="bib13">Coste et al., 2010</xref>; <xref ref-type="bibr" rid="bib14">Coste et al., 2012</xref>) with a well-established role in endothelial biology and vascular function (<xref ref-type="bibr" rid="bib63">Rode et al., 2017</xref>; <xref ref-type="bibr" rid="bib45">Li et al., 2014</xref>), and Piezo1 mRNA expression does not change upon LRRC8A KD. Also, <italic>Lrrc8a</italic> mRNA expression is the highest among all <italic>LRRC8</italic> genes expressed in HUVECs, 3-fold higher than <italic>Lrrc8a</italic> mRNA in 3T3-F442A adipocytes (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>), 15-fold higher than C2C12 myotubes (<xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>; <xref ref-type="fig" rid="fig6">Figure 6D</xref>), consistent with the prominent endogenous I<sub>Cl,SWELL</sub> currents present in HUVEC (<xref ref-type="fig" rid="fig1">Figure 1C–F</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>RNA sequencing of Ad-sh<italic>Scr</italic> and Ad-sh<italic>Lrrc8a</italic> transduced human umbilical vein endothelial cells (HUVECs).</title><p>(<bold>A</bold>) Heatmap analysis displaying top 25 upregulated or 25 downregulated genes between sh<italic>Scr</italic> and sh<italic>Lrrc8a</italic>. (<bold>B</bold>) IPA canonical pathway analysis of genes significantly regulated by sh<italic>Lrrc8a</italic> in comparison to sh<italic>Scr</italic> n = 3 for each group. For analysis with Ingenuity Pathway Analysis (IPA), Fragments Per Kilobase of transcripts per Million mapped reads (FPKM) cutoffs of 1.5, fold change of 1.5, and false discovery rate &lt;0.05 were utilized for significantly differentially regulated genes. (<bold>C</bold>) Expression levels of select <italic>LRRC8</italic> mRNA, classic endothelial markers, and mechanoresponsive ion channels in sh<italic>Scr</italic> and sh<italic>Lrrc8a</italic>-treated HUVECs. (<bold>D</bold>) Expression levels <italic>LRRC8a-e</italic> mRNA in HUVECs compared to data previously published from C2C12 myotubes (<xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>) and differentiated 3T3-F442A adipocytes (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>). For (<bold>C</bold>), statistical significance between the indicated values was calculated using an unpaired two-tailed Student’s t-test. Error bars represent mean ± s.e.m. n = 3, independent experiments. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6">Figure 6C</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig6-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6">Figure 6D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig6-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61313-fig6-v2.tif"/></fig></sec><sec id="s2-6"><title>Endothelial-targeted LRRC8A KO mice exhibit mild angiotensin-II stimulated hypertension and impaired retinal blood flow in the setting of T2D</title><p>To examine the functional consequences of endothelial LRRC8A ablation in vivo, we generated endothelial-targeted <italic>Lrrc8a</italic> knock-out mice (e<italic>Lrrc8a</italic> KO) by crossing <italic>Lrrc8a</italic> floxed mice (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>; <xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>; <xref ref-type="bibr" rid="bib36">Kang et al., 2018</xref>) with the endothelium-restricted CDH5-Cre mouse (CDH5-Cre<italic>; Lrrc8a <sup>fl/fl</sup></italic>; <xref ref-type="fig" rid="fig7">Figure 7A</xref>). Patch-clamp recordings of primary endothelial cells isolated from WT and e<italic>Lrrc8a</italic> KO mice (<xref ref-type="fig" rid="fig7">Figure 7B</xref>) reveal robust hypotonically activated currents (Hypo, 210 mOsm) in WT endothelial cells, which are DCPIB inhibited (<xref ref-type="fig" rid="fig7">Figure 7C&amp;E</xref>), while e<italic>Lrrc8a</italic> KO endothelial cells exhibit markedly reduced hypotonically activated currents (<xref ref-type="fig" rid="fig7">Figure 7D&amp;E</xref>). Consistent with this, IF staining of aortic ring explants from WT and e<italic>Lrrc8a</italic> KO mice confirmed LRRC8A ablation from CD31+ primary endothelial cells (<xref ref-type="fig" rid="fig7">Figure 7F&amp;G</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Endothelial-targeted <italic>Lrrc8a</italic> KO mice exhibit reduced phosphorylated endothelial nitric oxide synthase (p-eNOS) and mild angiotensin-II stimulated hypertension.</title><p>(<bold>A</bold>) Strategy for endothelium targeted <italic>Lrrc8a</italic> ablation to generate e<italic>Lrrc8a</italic> KO. (<bold>B</bold>) Isolation of murine primary endothelial cells from WT and e<italic>Lrrc8a</italic> KO using tdTomato reporter mice. (<bold>C–D</bold>) Current-voltage relationships of volume-regulatory anion channel (VRAC) current in isotonic (Iso, 300 mOsM) and hypotonic (Hypo, 210 mOsm) solution in response to voltage ramps from -100 to +100 mV over 500 ms in WT (<bold>C</bold>) and KO (<bold>D</bold>) primary murine endothelial cells. DCPIB (10 µM) inhibition in C (WT). (<bold>E</bold>) Mean outward (+100 mV) and inward (-100 mV) currents from WT (n = 3 cells) and e<italic>Lrrc8a</italic> KO (n = 3 cells). (<bold>F</bold>) Ex vivo aorta sprouting assay performed in aortic rings isolated from WT and e<italic>Lrrc8a</italic> KO mice and cultured in FGM media for 3 days at 37°C. Immunofluorescence staining with antibodies to LRRC8A (green), CD31 (red), LRRC8A+CD31+ (Merge) demonstrating endothelial-targeted <italic>Lrrc8a</italic> deletion. (<bold>G</bold>) Quantification of LRRC8A immunofluorescence staining in WT (n = 15) and e<italic>Lrrc8a</italic> KO (n = 15) endothelial cell tubes. (<bold>H–I</bold>) Representative images of aortic sections from WT (n = 3) and e<italic>Lrrc8a</italic> KO (n = 3) mice immunostained with p-eNOS (<bold>H</bold>, green), and immunofluorescence quantification of regions of WT (n = 5) and e<italic>Lrrc8a</italic> KO (n = 5) endothelium (<bold>I</bold>). Scale bar in (<bold>H</bold>) is 50 μm. (<bold>J–L</bold>) Tail-cuff systolic blood pressures of male (<bold>J</bold>) and female (<bold>K</bold>) WT (n = 5 males and 7 females) and e<italic>Lrrc8a</italic> KO (n = 5 males and 12 females) mice, and systolic blood pressures of male WT (n = 4) and e<italic>Lrrc8a</italic> KO (n = 5) mice under basal conditions and after 4 weeks of chronic angiotensin-II infusion (<bold>L</bold>). Statistical significance between the indicated values is calculated using a two-tailed unpaired Student’s t-test. Error bars represent mean ± s.e.m. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7">Figure 7E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig7-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7">Figure 7I</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig7-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig7sdata3"><label>Figure 7—source data 3.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7">Figure 7J</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig7-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig7sdata4"><label>Figure 7—source data 4.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7">Figure 7K</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig7-data4-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig7sdata5"><label>Figure 7—source data 5.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7">Figure 7l</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig7-data5-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61313-fig7-v2.tif"/></fig><p>Based on our findings that LRRC8A regulates AKT-eNOS signaling in HUVECs in vitro, we next examined p-eNOS in aortic endothelium by IF staining in WT and LRRC8A KO mice. Similar to results in LRRC8A KD HUVEC, we found reduced p-eNOS intensity in aortic endothelium of e<italic>Lrrc8a</italic> KO mice as compared to WT mice (<xref ref-type="fig" rid="fig7">Figure 7H,I</xref>).</p><p>Since eNOS signaling is central to blood pressure regulation, we next examined blood pressures in e<italic>Lrrc8a</italic> KO mice compared to WT controls (<italic>Lrrc8a</italic> <sup>fl/fl</sup> mice). Male mice exhibited no significant differences in systolic blood pressure under basal conditions (<xref ref-type="fig" rid="fig7">Figure 7J</xref>), while female mice were mildly hypertensive relative to WT mice (<xref ref-type="fig" rid="fig7">Figure 7K</xref>). However, after 4 weeks of angiotensin-II (Ang II) infusion, male e<italic>Lrrc8a</italic> KO mice developed exacerbated systolic hypertension as compared to Ang II-treated WT mice (<xref ref-type="fig" rid="fig7">Figure 7L</xref>). These data are consistent with endothelial dysfunction and impaired vascular relaxation in e<italic>Lrrc8a</italic> KO mice, resulting in a propensity for systolic hypertension.</p><p>As endothelial dysfunction may also result in impaired blood flow, we performed retinal imaging during intraperitoneal (i.p.) injection of fluorescein to assess retinal vessel blood flow and morphology in WT and e<italic>Lrrc8a</italic> KO mice. Mice raised on a regular diet had mild, non-significant impairments in retinal blood flow, based on the relative rate of rise of the fluorescein signal in retinal vessels (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>). There was evidence of mild focal narrowing of retinal vessels in e<italic>Lrrc8a</italic> KO as compared to WT mice (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1A,D&amp;E</xref>), with no significant differences in other parameters (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1F–K</xref>). In mice raised on high-fat high-sucrose (HFHS) diet, retinal blood flow was more severely impaired (<xref ref-type="fig" rid="fig8">Figure 8A–C</xref>) with significant focal and diffuse retinal vessel narrowing in e<italic>Lrrc8a</italic> KO mice compared to WT mice (<xref ref-type="fig" rid="fig8">Figure 8A,F–H</xref>, <xref ref-type="fig" rid="fig8s2">Figure 8—figure supplement 2</xref>, <xref ref-type="video" rid="fig8video1">Figure 8—video 1</xref>), and this relative difference was markedly worse in female compared to male mice. These findings are all consistent with endothelial dysfunction and impaired retinal vessel vasorelaxation due to reduced eNOS expression and activity, particularly in the setting of HFHS diet. Also consistent with impaired eNOS activity are reductions in vessel number (<xref ref-type="fig" rid="fig8">Figure 8E</xref>), vessel surface area (<xref ref-type="fig" rid="fig8">Figure 8H</xref>), number of end points (<xref ref-type="fig" rid="fig8">Figure 8K</xref>), branching index (<xref ref-type="fig" rid="fig8">Figure 8L</xref>), and increased lacunarity (<xref ref-type="fig" rid="fig8">Figure 8J</xref>). These parameters are all suggestive of diabetes-induced retinal vessel dysfunction in the e<italic>Lrrc8a</italic> KO mice, consistent with the loss of eNOS activity that is expected when insulin signaling is compromised (<xref ref-type="bibr" rid="bib6">Brooks et al., 2001</xref>; <xref ref-type="bibr" rid="bib41">Kondo et al., 2003</xref>). Notably, both WT and e<italic>Lrrc8a</italic> KO mice were found to be equally glucose-intolerant and insulin-resistant (<xref ref-type="fig" rid="fig8s3">Figure 8—figure supplement 3</xref>), indicating that these differences in microvascular dysfunction were not due to increased hyperglycemia and more severe diabetes in e<italic>Lrrc8a</italic> KO mice. However, while there were no differences in mean body weight or fat mass between WT and e<italic>Lrrc8a</italic> KO males raised on HFHS diet (<xref ref-type="fig" rid="fig8s4">Figure 8—figure supplement 4</xref>), female e<italic>Lrrc8a</italic> KO mice had higher body weights than WT female mice, and this was driven by an increase in total fat mass (<xref ref-type="fig" rid="fig8s4">Figure 8—figure supplement 4</xref>). Taken together, our findings reveal that LRRC8A is highly expressed in endothelium and functionally encodes endothelial VRAC. LRRC8A regulates basal, stretch, and shear-flow-mediated ERK, AKT-eNOS signaling, forms an LRRC8A-GRB2-Cav1-eNOS signaling complex, and regulates vascular function in vivo.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Endothelium-specific <italic>Lrrc8a</italic> KO mice exhibit exacerbated impairments retinal microvascular disease in the setting of type 2 diabetes.</title><p>(<bold>A</bold>) Representative fluorescein retinal angiograms of WT (top) and e<italic>Lrrc8a</italic> KO (bottom) male (left) and female (right) mice raised on a high-fat high-sucrose (HFHS) diet. Inset shows magnified view of retinal vessels. Quantification of major vessel fluorescence intensity over time after intraperitoneal (i.p.) fluorescein injection in (<bold>B</bold>) male (n = 3) and (<bold>C</bold>) female (n = 3) WT and e<italic>Lrrc8a</italic> KO mice. (<bold>D–K</bold>) Quantification of total retinal vessel intensity (<bold>D</bold>), total vessel number (<bold>E</bold>), vessel diameter (<bold>F</bold>), minimum vessel diameter (<bold>G</bold>), vessel area (<bold>H</bold>), total vessel length (<bold>I</bold>), lacunarity (<bold>J</bold>), number of end points (<bold>K</bold>), and branching index (<bold>L</bold>) of retinal vessels in WT and e<italic>Lrrc8a</italic> KO mice. Statistical significance between the indicated values for <bold>B</bold> and <bold>C</bold> was calculated using two-way analysis of variance (ANOVA) and (<bold>D–L</bold>) using a two-tailed unpaired Student’s t-test. Error bars represent mean ± s.e.m. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8">Figure 8B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8sdata2"><label>Figure 8—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8">Figure 8C</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8sdata3"><label>Figure 8—source data 3.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8">Figure 8D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8sdata4"><label>Figure 8—source data 4.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8">Figure 8E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-data4-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8sdata5"><label>Figure 8—source data 5.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8">Figure 8F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-data5-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8sdata6"><label>Figure 8—source data 6.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8">Figure 8G</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-data6-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8sdata7"><label>Figure 8—source data 7.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8">Figure 8H</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-data7-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8sdata8"><label>Figure 8—source data 8.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8">Figure 8I</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-data8-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8sdata9"><label>Figure 8—source data 9.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8">Figure 8J</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-data9-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8sdata10"><label>Figure 8—source data 10.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8">Figure 8K</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-data10-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8sdata11"><label>Figure 8—source data 11.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8">Figure 8L</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-data11-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61313-fig8-v2.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Endothelium-specific <italic>Lrrc8a</italic> KO mice exhibit mild retinal microvascular disease at baseline.</title><p>Representative fluorescein retinal angiograms of 13 week old WT (<bold>A</bold>) and e<italic>Lrrc8a</italic> KO (<bold>B</bold>) mice raised on a regular diet. Inset shows magnified view of retinal vessels. (<bold>C–E</bold>) Quantification of major vessel fluorescence intensity over time after intraperitoenal (i.p.) fluorescein injection (<bold>C</bold>), maximum vessel diameter (<bold>D</bold>), and minimum vessel diameter (<bold>E</bold>) in WT (n = 11 mice) and e<italic>Lrrc8a</italic> KO (n = 11 mice). (<bold>F–K</bold>) Quantification of explant area (<bold>F</bold>), lacunarity (<bold>G</bold>), vessel area (<bold>H</bold>), branching index (<bold>I</bold>), number of end points (<bold>J</bold>), and vessel length (<bold>K</bold>) in WT and e<italic>Lrrc8a</italic> KO mice. Significance between the indicated groups was calculated using a two-way analysis of variance (ANOVA) in (<bold>C</bold>) and a two-tailed Student’s t-test in (<bold>D–K</bold>). Error bars represent mean ± s.e.m. ***p&lt;0.001. Scale bar is 500 µm.</p><p><supplementary-material id="fig8s1sdata1"><label>Figure 8—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1C</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8s1sdata2"><label>Figure 8—figure supplement 1—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-figsupp1-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8s1sdata3"><label>Figure 8—figure supplement 1—source data 3.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-figsupp1-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8s1sdata4"><label>Figure 8—figure supplement 1—source data 4.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-figsupp1-data4-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8s1sdata5"><label>Figure 8—figure supplement 1—source data 5.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1G</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-figsupp1-data5-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8s1sdata6"><label>Figure 8—figure supplement 1—source data 6.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1H</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-figsupp1-data6-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8s1sdata7"><label>Figure 8—figure supplement 1—source data 7.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1I</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-figsupp1-data7-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8s1sdata8"><label>Figure 8—figure supplement 1—source data 8.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1J</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-figsupp1-data8-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8s1sdata9"><label>Figure 8—figure supplement 1—source data 9.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1K</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-figsupp1-data9-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61313-fig8-figsupp1-v2.tif"/></fig><fig id="fig8s2" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 2.</label><caption><title>Endothelium-specific <italic>Lrrc8a</italic> KO mice exhibit exacerbated impairments retinal microvascular disease in the setting of type 2 diabetes.</title><p>Three representative fluorescein retinal angiograms of WT and e<italic>Lrrc8a</italic> KO from male (<bold>A</bold>) and female (<bold>B</bold>) mice raised on a high-fat high-sucrose (HFHS) diet for 10 months. Scale bar is 500 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61313-fig8-figsupp2-v2.tif"/></fig><fig id="fig8s3" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 3.</label><caption><title>Glucose tolerance (GTT) and insulin tolerance (ITT) are not altered in endothelium-specific <italic>Lrrc8a</italic> KO mice (n = 13) compared to WT mice (n = 8) raised on a high-fat high-sucrose diet for 10 months.</title><p>Significance between the indicated groups was calculated using a two-way analysis of variance (ANOVA).</p><p><supplementary-material id="fig8s3sdata1"><label>Figure 8—figure supplement 3—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8s3">Figure 8—figure supplement 3</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-figsupp3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61313-fig8-figsupp3-v2.tif"/></fig><fig id="fig8s4" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 4.</label><caption><title>Body weight and body composition of WT and endothelium-specific <italic>Lrrc8a</italic> KO mice raised on a high-fat high-sucrose diet for 10 months.</title><p>(<bold>A–E</bold>) Male WT (n = 6) and e<italic>Lrrc8a</italic> KO (n = 7) mice body weight (<bold>A</bold>), %Lean mass (<bold>B</bold>), total lean mass (<bold>C</bold>), %Fat mass (<bold>D</bold>), total fat mass (<bold>E</bold>). (<bold>F–J</bold>) Female WT (n = 7) and e<italic>LRRC8A</italic> KO (n = 13) mice body weight (<bold>F</bold>), %Lean mass (<bold>G</bold>), total lean mass (<bold>H</bold>), %Fat mass (<bold>I</bold>), total fat mass (<bold>J</bold>). Significance between the indicated groups was calculated using a two-tailed Student’s t-test. Error bars represent mean ± s.e.m. *p&lt;0.05; **p&lt;0.01.</p><p><supplementary-material id="fig8s4sdata1"><label>Figure 8—figure supplement 4—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8s4">Figure 8—figure supplement 4</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-fig8-figsupp4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61313-fig8-figsupp4-v2.tif"/></fig><media id="fig8video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-61313-fig8-video1.mp4"><label>Figure 8—video 1.</label><caption><title>Retinal angiograms of WT (left) and e<italic>Lrrc8a</italic> KO (right) upon fluorescein injection intraperitoneally.</title></caption></media></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our findings demonstrate that the LRRC8 hetero-hexamer functionally encodes endothelial VRAC, whereby LRRC8A associates with GRB2 and Cav1 and positively regulates PI3K-AKT-eNOS and ERK1/2 signaling. LRRC8A depletion in HUVECs reduces pAKT2, pAKT1, p-eNOS, and pERK1/2 under basal conditions, and abrogates both stretch and shear-flow stimulated p-eNOS stimulation. We also discovered the ability of HUVECs to align along the direction of laminar shear flow is markedly impaired in LRRC8A KD cells – suggesting these cells have an impaired ability to either sense or respond to laminar shear flow (or both). These data reveal that LRRC8A-mediated PI3K-AKT signaling is conserved in endothelium, similar to previous observations in adipocytes (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>) and skeletal myotubes (<xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>), and in turn positively regulates eNOS expression and activity. Consistent with this mechanism, endothelial-targeted <italic>Lrrc8a</italic> ablation in vivo predisposes to microvascular dysfunction in the setting of T2D and to hypertension in response to Ang II infusion. These results are in line with the notion that LRRC8A depleted endothelium contributes to an insulin-resistant state in which impaired PI3K-AKT-eNOS signaling results in a propensity for vascular dysfunction (<xref ref-type="bibr" rid="bib38">Kearney et al., 2008</xref>; <xref ref-type="bibr" rid="bib52">Muniyappa and Sowers, 2013</xref>). Insulin-mediated regulation of NO is physiologically (<xref ref-type="bibr" rid="bib92">Zeng and Quon, 1996</xref>; <xref ref-type="bibr" rid="bib91">Zeng et al., 2000</xref>; <xref ref-type="bibr" rid="bib50">Montagnani et al., 2002</xref>) and pathophysiologically (<xref ref-type="bibr" rid="bib77">Steinberg et al., 1996</xref>) important, as NO has vasodilatory (<xref ref-type="bibr" rid="bib60">Quillon et al., 2015</xref>; <xref ref-type="bibr" rid="bib57">Palmer et al., 1987</xref>), anti-inflammatory (<xref ref-type="bibr" rid="bib37">Kataoka et al., 2002</xref>), antioxidant (<xref ref-type="bibr" rid="bib12">Clapp et al., 2004</xref>), and antiplatelet effects (<xref ref-type="bibr" rid="bib68">Schäfer et al., 2004a</xref>; <xref ref-type="bibr" rid="bib69">Schäfer et al., 2004b</xref>; <xref ref-type="bibr" rid="bib61">Radomski et al., 1987a</xref>; <xref ref-type="bibr" rid="bib62">Radomski et al., 1987b</xref>). Impaired NO-mediated vascular reactivity is a predictor of future adverse cardiac events (<xref ref-type="bibr" rid="bib67">Schächinger et al., 2000</xref>) and portends increased risk of atherosclerosis (<xref ref-type="bibr" rid="bib9">Bugiardini et al., 2004</xref>). Consistent with these NO-mediated effects, the RNA sequencing data derived from LRRC8A KD HUVECs revealed enrichment in inflammatory, cell adhesion, and proliferation pathways (GADD45, IL-8, mTOR, TREM1 signaling) that may arise from LRRC8A-mediated dysregulation of eNOS activity. Moreover, <italic>Lrrc8a</italic> mRNA is highly expressed in HUVECs relative to adipocyte and myotube cell lines examined previously (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>; <xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>), higher than many endothelial genes, and higher than other mechanosensitive (Piezo1) and mechanoresponsive (TRPV4) ion channels with well-established roles in endothelial biology (<xref ref-type="bibr" rid="bib75">Sonkusare et al., 2012</xref>; <xref ref-type="bibr" rid="bib63">Rode et al., 2017</xref>; <xref ref-type="bibr" rid="bib45">Li et al., 2014</xref>; <xref ref-type="bibr" rid="bib11">Cappelli et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Dalsgaard et al., 2016</xref>; <xref ref-type="bibr" rid="bib18">Dunn et al., 2013</xref>; <xref ref-type="bibr" rid="bib19">Earley et al., 2005</xref>; <xref ref-type="bibr" rid="bib30">Harraz et al., 2018</xref>; <xref ref-type="bibr" rid="bib49">Mercado et al., 2014</xref>; <xref ref-type="bibr" rid="bib76">Sonkusare et al., 2014</xref>).</p><p>In addition to reductions in AKT-eNOS signaling, LRRC8A depletion in HUVECs also reduced ERK1/2 signaling. This decrease in pERK1/2 suggests impaired MAPK signaling which is connected to the insulin receptor by GRB2-SOS. Indeed, we also found that LRRC8A and GRB2 interact in HUVECs, and this may provide the molecular mechanism for the observed defect in ERK signaling. Interestingly, GRB2-MAPK signaling is thought to promote angiogenesis, migration, and proliferation (<xref ref-type="bibr" rid="bib95">Zhao et al., 2011</xref>), so reductions in ERK1/2 signaling would be predicted to inhibit these processes. One hypothesized mechanism of LRRC8A-mediated regulation of ERK1/2 and AKT2-eNOS signaling involves non-conductive protein-protein signaling via the LRRD as described previously in adipocytes (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>; <xref ref-type="bibr" rid="bib28">Gunasekar et al., 2019</xref>). An alternative hypothesis is that LRRC8A-mediated VRAC channel activity may alter endothelial membrane potential to regulate other endothelial ion channels, such as Piezo1 or TRPV4, and downstream calcium signaling to influence downstream signaling. Future studies will further delineate the molecular mechanisms of LRRC8A regulation of intracellular signaling in endothelial cells and vascular function, and also directly explore whether endothelial LRRC8A-mediated VRAC channel complexes are themselves mechanoresponsive, as suggested in prior studies in other cell types (<xref ref-type="bibr" rid="bib7">Browe and Baumgarten, 2003</xref>; <xref ref-type="bibr" rid="bib8">Browe and Baumgarten, 2006</xref>).</p><p>Another curious observation that warrants further exploration is the reduction in basal <italic>Akt2</italic> and <italic>NOS2</italic> (eNOS) mRNA expression upon LRRC8A KD in HUVECs, which is also observed at the protein level. We can only speculate that LRRC8A is somehow regulating <italic>Akt2</italic> and <italic>eNOS</italic> gene expression. Both PI3K and ERK1/2 signaling pathways have been described to regulate total eNOS expression (<xref ref-type="bibr" rid="bib89">Wu, 2002</xref>), and we observe reductions in both PI3K and ERK1/2 signaling in LRRC8A KD HUVECs, so reductions in eNOS expression are certainly consistent with disruptions in these signaling pathways. Consistent with this conserved biology with respect to LRRC8A signaling, we also observed significant twofold reductions in AKT2 expression upon <italic>Lrrc8a</italic> deletion in both 3T3-F442A adipocytes (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>) and C2C12 myotubes (<xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>), in addition to reductions in NOS2 (iNOS) (<xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>) in adipocytes and NOS1 (neuronal NOS) in C2C12 myotubes (<xref ref-type="bibr" rid="bib44">Kumar et al., 2020</xref>). Collectively, these findings across multiple cell types support a PI3K and ERK1/2 mediated mechanism of regulation of eNOS and AKT2 gene expression.</p><p>The phenotype of endothelial-targeted <italic>Lrrc8a</italic> KO (e<italic>Lrrc8a</italic> KO) mice are consistent with a reduction in eNOS and p-eNOS as these mice exhibit mild hypertension at baseline (females) and exacerbated hypertension in response to chronic angiotensin infusion, suggesting a modulatory effect on vascular reactivity. Similarly, retinal blood flow is only mildly impaired in e<italic>Lrrc8a</italic> KO mice raised on a regular diet, with some evidence of microvascular disease. However, both retinal blood flow and retinal vessel morphology are markedly impaired in obese-T2D, insulin-resistant e<italic>Lrrc8a</italic> KO mice raised on an HFHS diet compared to controls. This is consistent with a synergistic role of endothelial e<italic>Lrrc8a</italic> ablation and T2D/obesity in the pathogenesis of vascular disease. Our results suggest that reductions in LRRC8A signaling may contribute to impaired vascular function observed in humans in response to insulin and/or shear stress in the setting of obesity (<xref ref-type="bibr" rid="bib3">Arcaro et al., 1999</xref>; <xref ref-type="bibr" rid="bib80">Tack et al., 1998</xref>; <xref ref-type="bibr" rid="bib87">Westerbacka et al., 1999</xref>; <xref ref-type="bibr" rid="bib88">Williams et al., 2006</xref>) and insulin resistance (<xref ref-type="bibr" rid="bib53">Murphy et al., 2007</xref>).</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type (species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">Genetic reagent (<italic>Mus musculus)</italic></td><td valign="top"><italic>eLrrc8a KO</italic> (<italic>Lrrc8a<sup>fl/fl</sup></italic>)</td><td valign="top">This paper</td><td valign="top">Sah lab</td><td valign="top">SWELL1 is a regulator of adipocyte size, insulin signaling, and glucose homeostasis (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>)</td></tr><tr><td valign="top">Strain, strain background (<italic>Mus musculus)</italic></td><td valign="top"><italic>CDH5-Cre</italic></td><td valign="top">Gift from Dr. Kaikobad Irani</td><td valign="top"/><td valign="top">Vikram, A, <italic>Nature Communications</italic> 2016</td></tr><tr><td valign="top">Strain, strain background (<italic>Mus musculus)</italic></td><td valign="top">Rosa26-tdTomato</td><td valign="top">Jackson lab</td><td valign="top">Jax 007914 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:007914">IMSR_JAX:007914</ext-link></td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">HUVECs</td><td valign="top">ATCC</td><td valign="top">Cat#CRL-2922 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_3901">CVCL_3901</ext-link></td><td valign="top">Human primary cells</td></tr><tr><td valign="top">Biological sample (<italic>Mus musculus)</italic></td><td valign="top">Endothelial primary cell</td><td valign="top"><italic>Lrrc8a<sup>fl/fl</sup></italic></td><td valign="top"/><td valign="top">Freshly isolated from <italic>Lrrc8a<sup>fl/fl</sup></italic> mice</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-ß-actin (rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">Cat#8457s, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10950489">AB_10950489</ext-link></td><td valign="top">WB (1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-total Akt <break/>(rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">Cat#4685s, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2225340">AB_2225340</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Akt1 <break/>(rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">Cat#2938s, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_915788">AB_915788</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-p-eNOS <break/>(rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">Cat#9571, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_329837">AB_329837</ext-link></td><td valign="top">WB (1:1000) <break/>IF (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-p-eNOS <break/>(rabbit polyclonal)</td><td valign="top">Invitrogen</td><td valign="top">Cat#PA5-104858, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2816331">AB_2816331</ext-link></td><td valign="top">IF (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Akt2 <break/>(rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">Cat#3063s, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2225186">AB_2225186</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-p-AS160 <break/>(rabbit polyclonal)</td><td valign="top">Cell Signaling</td><td valign="top">Cat#4288s, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10545274">AB_10545274</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-total eNOS <break/>(rabbit polyclonal)</td><td valign="top">Cell Signaling</td><td valign="top">Cat#32027, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2728756">AB_2728756</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-PECAM <break/>(rabbit monoclonal)</td><td valign="top">Sigma</td><td valign="top">Cat#SAB4502167 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10762600">AB_10762600</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-VEGFR2 <break/>(goat polyclonal)</td><td valign="top">R and D Systems</td><td valign="top">Cat#BAF357 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_356414">AB_356414</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti- pS6 ribosomal <break/>(rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">Cat#5364s, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10694233">AB_10694233</ext-link></td><td valign="top">WB (1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti- GAPDH <break/>(rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">Cat#5174s, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1062202">AB_1062202</ext-link></td><td valign="top">WB (1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-pErk1/2 <break/>(rabbit polyclonal)</td><td valign="top">Cell Signaling</td><td valign="top">Cat#9101s, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_331772">AB_331772</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Total Erk1/2 <break/>(rabbit polyclonal)</td><td valign="top">Cell Signaling</td><td valign="top">Cat#9102s, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_330744">AB_330744</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Grb2 <break/>(mouse monoclonal)</td><td valign="top">BD</td><td valign="top">Cat#610111s, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_397517">AB_397517</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Grb2 <break/>(rabbit monoclonal)</td><td valign="top">Santa Cruz</td><td valign="top">Cat#sc-255, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_631602">AB_631602</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-LRRC8A <break/>(rabbit polyclonal)</td><td valign="top">Pacific antibodies</td><td valign="top">Custom made</td><td valign="top">Epitope: QRTKSRIEQGIVDRSE, <break/>WB (1:1000), LRRC8A is a glucose sensor regulating ß-cell excitability and systemic glycemia (<xref ref-type="bibr" rid="bib36">Kang et al., 2018</xref>)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-CD31 <break/>(rabbit polyclonal)</td><td valign="top">Thermo Fisher</td><td valign="top">Cat#MA3105, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_223592">AB_223592</ext-link></td><td valign="top">IF (1:100)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-IgG <break/>(normal mouse IgG)</td><td valign="top">Santa Cruz</td><td valign="top">Cat#sc-2027, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_737197">AB_737197</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-rabbit-HRP</td><td valign="top">BioRad</td><td valign="top">Cat#170–6515, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11125142">AB_11125142</ext-link></td><td valign="top">WB (1:10,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-mouse-HRP</td><td valign="top">BioRad</td><td valign="top">Cat#170–5047, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11125753">AB_11125753</ext-link></td><td valign="top">WB (1:10,000)</td></tr><tr><td valign="top">Transfected construct (human)</td><td valign="top">si<italic>Lrrc8a</italic></td><td valign="top">Invitrogen</td><td valign="top">Cat#4392420</td><td valign="top">Assay ID: s32107 <break/>Transfected construct human</td></tr><tr><td valign="top">Transfected construct (human)</td><td valign="top">Non-targeting control</td><td valign="top">Invitrogen</td><td valign="top">Cat#4390846</td><td valign="top">Transfected construct human</td></tr><tr><td valign="top">Transfected construct (human)</td><td valign="top">siPORTamine</td><td valign="top">Invitrogen</td><td valign="top">Cat#AM4503</td><td valign="top"/></tr><tr><td valign="top">Transfected construct (human)</td><td valign="top">Opti-MEM</td><td valign="top">Invitrogen</td><td valign="top">Cat#11058–021</td><td valign="top"/></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">Ad5-U6-h<italic>Lrrc8a</italic>-shRNA-mCherry</td><td valign="top">Vector biolabs</td><td valign="top">shADV- <break/>653 214592</td><td valign="top"/></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">Ad5-U6-<italic>Scr</italic>-shRNA-mCherry</td><td valign="top">Vector biolabs</td><td valign="top">3086</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">RNA isolation (PureLink RNA mini kit)</td><td valign="top">Invitrogen</td><td valign="top">12183018A</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">GraphPad Prism8</td><td valign="top"/><td valign="top">La Jolla California USA, <ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com">http://www.graphpad.com</ext-link>’ RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Fiji, ImageJ</td><td valign="top"><xref ref-type="bibr" rid="bib70">Schindelin et al., 2012</xref> <break/>(PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/22743772">22743772</ext-link>)</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002285">SCR_002285</ext-link></td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">DAPI stain</td><td valign="top">Thermofisher</td><td valign="top">Cat#T3605</td><td valign="top">1:10,000</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animals</title><p>The institutional animal care and use committee of the University of Iowa and Washington University School of Medicine approved all experimental procedures involving animals. All mice were housed in temperature, humidity, and light controlled environment and allowed water access and food. Both male and female <italic>Lrrc8a<sup>fl/fl</sup></italic> (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Kang et al., 2018</xref>) (WT), <italic>CDH5-Cre;Lrrc8a<sup>fl/fl</sup></italic> (<italic>eLrrc8a</italic> KO) mice were generated and used in these studies. <italic>CDH5-Cre</italic> mice were obtained from Dr. Kaikobad Irani (University of Iowa, IA). In a subset of experiments, 5–8 week old <italic>Lrrc8a<sup>fl/fl</sup></italic> and <italic>CDH5-Cre;Lrrc8a<sup>fl/fl</sup></italic> mice were switched to HFHS (high-fat high-sucrose rodent diet, Research Diets, Inc, Cat# D12331) for at least 10 months. <italic>CDH5-Cre</italic> mice were crossed with <italic>Rosa26-tdTomato</italic> (Jax# 007914) reporter mice to identify CDH5+ cells for primary endothelium patch-clamp studies.</p></sec><sec id="s4-2"><title>Antibodies</title><p>Rabbit polyclonal anti-LRRC8A antibody was generated against the epitope QRTKSRIEQGIVDRSE (Pacific Antibodies) (<xref ref-type="bibr" rid="bib36">Kang et al., 2018</xref>). All other primary antibodies were purchased from Cells Signaling: anti-ß-actin (#8457), Total Akt (#4685S), Akt1 (#2938), Akt2 (#3063), p-eNOS (#9571), Total eNOS (#32027), p-AS160 (#4288), p-p70 S6 Kinase (#9205S), pS6 Ribosomal (#5364S), GAPDH (#5174), pErk1/2 (#9101), Total Erk1/2 (#9102). Anti-LRRC8A antibody was custom made as described previously (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Kang et al., 2018</xref>). A second p-eNOS antibody was purchased from Invitrogen (Cat#PA5-104858) and used to compare with anti-p-eNOS from Cell Signaling (#9571) for p-eNOS IF staining. Purified mouse anti-Grb2 was purchased from BD (610111) and Santa Cruz (#sc-255). Rabbit IgG was purchased from Santa Cruz (sc-2027). Anti-CD31 was purchased from Thermo Fisher (MA3105).</p></sec><sec id="s4-3"><title>Electrophysiology</title><p>All recordings were performed in the whole-cell configuration at room temperature (RT), as previously described (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Kang et al., 2018</xref>). Briefly, currents were measured with either an Axopatch 200B amplifier or a MultiClamp 700B amplifier (Molecular Devices) paired to a Digidata 1550 digitizer. Both amplifiers used pClamp 10.4 software. The intracellular solution contained (in mM): 120 L-aspartic acid, 20 CsCl, 1 MgCl<sub>2</sub>, 5 EGTA, 10 HEPES, 5 MgATP, 120 CsOH, 0.1 GTP, pH 7.2 with CsOH. The extracellular solution for hypotonic stimulation contained (in mM): 90 NaCl, 2 CsCl, 1 MgCl<sub>2</sub>, 1 CaCl<sub>2</sub>, 10 HEPES, 5 glucose, 5 mannitol, pH 7.4 with NaOH (210 mOsm/kg). The isotonic extracellular solution contained the same composition as above except for mannitol concentration of 105 (300 mOsm/kg). The osmolarity was checked by a vapor pressure osmometer 5500 (Wescor). Currents were filtered at 10 kHz and sampled at 100 µs interval. The patch pipettes were pulled from borosilicate glass capillary tubes (WPI) by a P-87 micropipette puller (Sutter Instruments). The pipette resistance was ~4–6 MO when the patch pipette was filled with intracellular solution. The holding potential was 0 mV. Voltage steps (500 ms) were elicited from 0 mV holding potential from -100 to +100 mV in 20 mV increments every 0.6 s. Voltage ramps from -100 to +100 mV (at 0.4 mV/ms) were applied every 4 s.</p></sec><sec id="s4-4"><title>Adenoviral KD</title><p>HUVECs were plated at 550,000 cell/well in 12-well plates. Cells were grown for 24 hr in the plates and transduced with either human adenovirus type 5 with sh<italic>Lrrc8a</italic> (sh<italic>Lrrc8a</italic>: Ad5-mCherry-U6-h<italic>Lrrc8a</italic>-shRNA, 2.2 × 10<sup>10</sup> PFU/ml [shADV-214592], Vector Biolabs) or a scrambled non-targeting control (sh<italic>Scr</italic>: Ad5-U6-scramble-mCherry, 1 × 10<sup>10</sup> PFU/ml) at a multiplicity of infection of 50 for 12 hr, and studies performed 3–4 days after adenoviral transduction. The shLRRC8a targeting sequence is: <named-content content-type="sequence">GCA CAA CAT CAA GTT CGA CGT</named-content>.</p></sec><sec id="s4-5"><title>siRNA KD</title><p>HUVECs were plated at 360,000 cell/well in six-well plates. Cells were grown for 24 hr (90–95% confluency) and transduced with either a silencer select siRNA with si<italic>LRRC8a</italic> (Cat#4392420, sense: <named-content content-type="sequence">GCAACUUCUGGUUCAAAUUTT</named-content> antisense: <named-content content-type="sequence">AAUUUGAACCAGAAGUUGCTG</named-content>, Invitrogen) or a non-targeting control silencer select siRNA (Cat#4390846, Invitrogen), as described previously (<xref ref-type="bibr" rid="bib40">Koh et al., 2008</xref>). The si<italic>LRRC8a</italic> used targets a different sequence from the shRNA described above. Briefly, siRNAs were transduced twice, 24 and 72 hr after HUVEC plating. Each siRNA was combined with Opti-MEM (285.25 µl, Cat#11058-021, Invitrogen) siPORT amine (8.75 µl, Cat#AM4503, Invitrogen) and the silencer select siRNA (6 µl) in a final volume of 300 µl. HUVECs were transduced over a 4 hr period at 37°C, using DMEM +1% FBS. After transduction, the cells were returned to media containing M199, 20% FBS, 0.05 g heparin sodium salt, and 15 mg ECGS. Cell lysates were collected at basal conditions on day 4.</p></sec><sec id="s4-6"><title>Isolation of mouse lung endothelial cells</title><p>Isolation of mouse lung endothelial cells was performed according to the following protocol: Day 1 – Incubate sheep anti-rat IgG Dynabeads (Invitrogen) overnight with PECAM (Sigma, #SAB4502167) and VEGFR2 (R and D Systems, #BAF357) antibodies at 4°C in PBS with gentle agitation. Day 2 – Lungs were removed from the mice, washed in 10% FBS/DMEM, minced into 1–2 mm squares, and digested with Collagenase Type I (2 mg/ml, Gibco) at 37°C for 1 hr with agitation. The cellular digest was filtered through a 70 µm cell strainer, centrifuged at 1500 rpm, and the cells immediately incubated with the antibody coated Dynabeads at RT for 20 min. The bead-bound cells were recovered with a magnet, washed two times with PBS, and plated overnight on collagen type I (100 μg/ml) coated coverslips. The endothelial cells were maintained in a growth media of M199, 20% FBS, 0.05 g heparin sodium salt, 50 mg/ml ECGS, and 1× anti-anti.</p></sec><sec id="s4-7"><title>Cell culture</title><p>HUVECs were purchased from ATCC and were grown in MCDB-131-complete media overnight. HUVECs for basal condition collection were grown in growth media of M199, 20% FBS, 0.05 g heparin sodium salt (Cat#9041-08-1, Alfa Aesar), and 15 mg ECGS (Cat#02-102, Millipore Sigma). Cells were routinely cultured on 1% of gelatin-coated plates at 37°C at 5% CO<sub>2</sub>. For insulin stimulation (Cat#SLBW8931), cells were serum starved for at least 13 hr in 1% FBS (Atlanta Bio selected, Cat#S11110) or without FBS using endothelial cells growth basal medium (Lonza Cat#cc-3121) instead of MCDB-131-complete media. Insulin stimulation was used for the times indicated at 100 nM.</p></sec><sec id="s4-8"><title>Immunoblotting</title><p>Cells were harvested in ice-cold lysis buffer (150 mM NaCl, 20 mM HEPES, 1% NP-40, 5 mM EDTA, pH 7.5) with added proteinase/phosphatase inhibitor (Roche). Cells were kept on ice with gentle agitation for 20 min to allow complete lysis. Lysate scraped into 1.5 ml tubes and cleared of debris by centrifugation at 14,000 × <italic>g</italic> for 20 min at 4°C. Supernatants were transferred to fresh tube and solubilized protein was measured using a DC protein assay kit (Bio-Rad). For immunoblotting, an appropriate volume of 1× Laemmli (Bio-Rad) sample loading buffer was added to the sample (10 µg of protein), which then heated at 90°C for 5 min before loading onto 4–20% gel (Bio-Rad). Proteins were separated using running buffer (Bio-Rad) for 2 hr at 150 V. Proteins were transferred to PVDF membrane (Bio-Rad) and membrane blocked in 5% (w/v) BSA in TBST or 5% (w/v) milk in TBST at RT for 2 hr. Blots were incubated with primary antibodies at 4°C overnight, followed by secondary antibody (Bio-Rad, Goat-anti-mouse #170–5047, Goat-anti-rabbit #170–6515, all used at 1:10,000) at RT for 1 hr. Membranes were washed three times and incubated in enhanced substrate Clarity (Bio-Rad) and imaged using a ChemiDoc XRS using Image Lab (Bio-Rad) for imaging and analyzing protein band intensities. ß-Actin or GAPDH levels were quantified to correct for protein loading.</p></sec><sec id="s4-9"><title>Immunoprecipitation</title><p>Cells were seeded on gelatin-coated 10 cm dishes in complete media for 24 hr. Adenoviruses, Ad5-mCherry-U6-h<italic>Lrrc8a</italic>-shRNA or Ad5-U6-<italic>Scr</italic>-mCherry were added to cells for 12 hr. After 4 days cells were serum starved for 16 hr with basal media containing 1% serum before stimulation with insulin (10 nM/ml). Cells were harvested in ice-cold lysis buffer (150 mM NaCl, 20 mM HEPES, 1% NP-40, 5 mM EDTA, pH 7.5) with added proteinase/phosphatase inhibitor (Roche) and kept on ice with gentle agitation for 15 min to allow complete lysis. Lysates were incubated with anti-Grb2 antibody (20 µg/ml) or control rabbit IgG (20 µg/ml, Santa Cruz sc-2027) rotating end over end overnight at 4°C. Protein G Sepharose beads (GE) were added to this for a further 4 hr before samples were centrifuged at 10,000 × <italic>g</italic> for 3 min and washed three times with RIPA buffer and re-suspended in laemmli buffer (Bio-Rad), boiled for 5 min, separated by SDS-PAGE gel followed by the Western blot protocol.</p></sec><sec id="s4-10"><title>Stretch assay</title><p>Equal amounts of cells were plated in each well in six well plated BioFlex coated with Laminin (BF-3001CCase) culture plate and seeded to ~90% confluence. Plates were placed into a FlexCell Jr. Tension System (FX-6000T) and incubated at 37°C with 5% CO<sub>2</sub>. Prior to stretch stimulation, basal media of 1% FBS was added for 16 hr. Cells on flexible membrane were subjected to static stretch with the following parameter: a stretch of 0.1% and 5% with static strain. Cells were stretched for 5, 30, 60, or 180 min. Cells were then lysed and protein isolated for subsequent Western blots.</p></sec><sec id="s4-11"><title>Laminar flow studies</title><p>HUVECs were grown in 1× M199 media (Gibco, Cat#11043-023) supplemented with 20% FBS (Gibco, Cat#16140-071), 50 mg bovine hypothalamus extract, and 0.01% heparin until full confluence in six-well plates. The cells were transfected twice across 3 days with 100 nM of siRNA for the <italic>Lrrc8a</italic> gene (si<italic>Lrrc8a</italic>) (Invitrogen, Cat#4392421, assay #:s32107) and a negative siRNA control (siControl) (Invitrogen, Cat#43900846) using siPORTAmine transfection agent (Invitrogen, Cat#AM4503) following the manufacturer recommendations (<xref ref-type="bibr" rid="bib40">Koh et al., 2008</xref>). Twenty-four hours after the final siRNA treatment, cells were transferred to µ-Slide 0.4 I Luer slide (iBidi, Cat#80176) and incubated overnight at 37°C, 5% CO<sub>2</sub>, and 95% humidity. The slides were then cultured for 24 hr in a microscope stage incubator (Invitrogen, EVOS7000) under conditions of constant laminar flow at 15 dynes/cm<sup>2</sup>/s (Flocel Inc, Cat#QPL1010) and images acquired every 20 min. The peristaltic pump was converted to be laminar through the utilization of dampers on the outflow tracts of the pump. Efficacy in the generation of laminar flow was confirmed through the imaging of Q-Dots in the circulating media prior to the experiment (Invitrogen, Cat#Q21721MP). At the termination of the experiment, the cells were rinsed with 1× PBS and fixed with 4% paraformaldehyde (PFA) for downstream immunostaining applications.</p></sec><sec id="s4-12"><title>Immunostaining for laminar flow studies</title><p>To detect the levels of p-eNOS, the cell monolayer was stained with the anti-rabbit polyclonal antibody p-eNOS (Invitrogen, Cat#PA5104858 or Cell Signaling, Cat#9571), at a final dilution of 1:200 and a secondary anti-rabbit GFP AlexaFluor 488 (Invitrogen, Cat#R37116) at 1:2000 dilution. The slides were immunostained following the basic protocol: (1) 30 min RT incubation in Tris-Glycine; (2) 1 hr RT incubation ± permeabilization with 0.01% TritonX-100; (3) 2 hr RT incubation in blocking solution (5% Sheep Serum, 1% Roche Blocking Buffer in PBST); (4) 1 hr at RT – overnight 4°C incubation with 1:200 primary antibody unless otherwise noted; (5) wash with PBST; (6) 2–3 hr RT incubation with 1:2000 secondary antibody in 5% Sheep Serum, 1% Roche Blocking Buffer in PBST; (7) wash with PBST and imaging analysis. The samples were observed under light microscopy using a Nikon Ti2. Quantification of immunostaining intensity was performed using ImageJ/Fiji (<xref ref-type="bibr" rid="bib70">Schindelin et al., 2012</xref>).</p></sec><sec id="s4-13"><title>Immunofluorescence imaging</title><p>Cells were plated on gelatin-coated glass coverslips. Cells on coverslip were washed in PBS and fixed with 2% (w/v) PFA for 20 min at RT. PFA was washed three times with PBS and permeabilized in PBS containing 0.2% Triton X-100 for 5 min at RT. Cells on coverslips were washed in PBS and blocked for 30 min at RT with TBS containing 0.1% Tween-20% and 5% BSA. Cells on coverslip were incubated overnight at 4°C with primary antibody (1:250) in TBS containing 0.1% Tween-20% and 1% BSA. Cells were then washed in PBS five times and incubated for 2 hr at RT with 5% BSA in TBST. Cells were washed three times in TBST and then incubated with secondary antibodies at 1:1000 dilution (Invitrogen, Anti-Rabbit 488, A11070; Anti-mouse 568, A11019; Anti-mouse 488, A11017) for 1 hr at RT. Coverslips were then incubated for 10 min with Topro 3 (T3605, Thermofisher) or mounted with mounting media containing DAPI (Invitrogen) to visualize nuclei. Images were taken using Axiocam 503 Mono Camera controlled by Zeiss Blue using a Plan-Apochromate 40× oil immersion objective.</p></sec><sec id="s4-14"><title>Immunohistochemistry of thoracic aorta sections</title><p>Mouse thoracic aortas were dissected and immediately fixed in 10% formalin. The formalin fixed aortas were embedded in paraffin and 5 µm sections were cut by automated microtome and mounted on positively charged slides. Slides were deparaffinized with Histoclear and hydrated with 100% ethanol, 75% ethanol, 50% ethanol, and then distilled water. To achieve the antigen retrieval, slides were steamed in Citrate buffer at pH 6 (DAKO Target retrieval buffer S1699, DAKO) for 30 min and subsequently cooled for 30 min. Furthermore, to inhibit the endogenous peroxides, slides were quenched with 3% H<sub>2</sub>O<sub>2</sub> for 10 min. Slides were washed with distilled water, then 1× PBS and blocked with 1% BSA in 1× PBS for 1 hr. After washing with 1× PBS, slides were incubated with p-eNOS antibody (1:500 dilution) overnight in the humidified chamber at 4°C. Slides were washed two times with 1× PBS and incubated with secondary antibody (AF488, Invitrogen, 1:1000 dilution) for 1 hr. Subsequently slides were washed with 1× PBS three times and mounted with DAPI added mounting media with coverslip. The slides were imaged by Zeiss LSM700 confocal microscope (10× objective).</p></sec><sec id="s4-15"><title>Ex vivo sprouting angiogenesis</title><p>Following Avertin injection and cervical dislocation, aortas were dissected and connective tissue removed, and then washed with PBS with 50 µg/ml penicillin and streptomycin. Using iris scissors, the aorta was cut into aortic rings of 1– 2 mm cross-sectional slices; 50 µl of Matrigel was used to coat the center of coverslips in 24-well plates for 2 hr at 37°C in the incubator to solidify the Matrigel. Aorta rings were then seeded and transplanted on Matrigel (BD Biosciences, Cat#356231) on coverslips. After seeding the aortic rings, plates were incubated at 37°C without medium for 10 min to allow the ring to attach to the Matrigel. Complete medium was added to each well and incubated at 37°C with 5% CO<sub>2</sub> for 48–72 hr. Phase contrast photos of individual explants were taken using a 10×/0.75 NA objective Olympus IX73 microscope (Olympus, Japan) fitted with camera (Orca flash 4.0+, Hamamatsu, Japan). Cells were incubated with LRRC8A (1:250) and CD31 (1:250) primary antibodies in 0.1% Tween-20% and 1% BSA overnight, and then incubated with secondary antibodies (Invitrogen, Anti-Rabbit 488, A11070; Anti-Mouse 568, A11019). Cells were then incubated for 10 min with Topro 3 (T3605, Thermofisher) at RT.</p></sec><sec id="s4-16"><title>Retinal imaging</title><p>Ketamine (Akorn Animal Health, 100 mg/ml) was prepared and mixed with xylazine, then stored at RT. Animals were anesthetized with 87.5/12 mg/kg body weight via i.p. injection. Eyes were topically anesthetized with proparacaine and dilated with tropicamide. Fluorescein (100 mg/ml, Akorn Inc) diluted with sterile saline was administered by i.p. injection (50 µl), and mice were positioned on Micron imaging platform. Images of the eyes were taken from the start of fluorescein infusion with the Micron camera with a 450–650 nm excitation filter and 469–488 nm barrier filter at 30 frame/s using Micron software for 30 s. Data were converted into tiff image for further analysis.</p></sec><sec id="s4-17"><title>Ang II infusion</title><p>Infusion studies were carried out using Azlet osmotic minipumps (Model 1004). Ang II (BACHEM) dissolved in saline was filled in the minipumps and were prepared to maintain infusion rate of 600 ng/kg/min for 4 weeks. The mice were anesthetized under 2% isofluorane and the minipumps were implanted subcutaneously on the dorsal aspect of the mice.</p></sec><sec id="s4-18"><title>Blood pressure recordings</title><p>Systolic tail-cuff blood pressure (BP) measurements were carried out using computerized tail-cuff system BP-2000 (Visitech Systems) at the same time of day. Mice were first acclimated to the device by performing 3 days of measurements (20 sequential measurements/day) and then mean blood pressure readings were obtained by averaging 3–5 days of measurements (not inclusive of the 3 acclimation days).</p></sec><sec id="s4-19"><title>RNA sequencing</title><p>RNA quality was assessed by Agilent BioAnalyzer 2100 by the University of Iowa Institute of Human Genetics, Genomics Division. RNA integrity numbers greater than eight were accepted for RNAseq library preparation. RNA libraries of 150 bp PolyA-enriched RNA were generated, and sequencing was performed on a HiSeq 4000 genome sequencing platform (Illumina). Sequencing results were uploaded and analyzed with BaseSpace (Illumina). Sequences were trimmed to 125 bp using FASTQ Toolkit (Version 2.2.0) and aligned to <italic>Homo sapiens</italic> HG19 (refseq) using RNA-Seq Alignment (Version 1.1.0). Transcripts were assembled and differential gene expression was determined using Cufflinks Assembly and DE (Version 2.1.0). Ingenuity Pathway Analysis (QIAGEN) was used to analyze significantly regulated genes which were filtered using cutoffs of &gt;1.5 fragments per kilobase per million reads, &gt;1.5-fold changes in gene expression, and a false discovery rate of &lt;0.05. Heatmaps were generated to visualize significantly regulated genes. Data have been deposited in GEO (accession# TBD).</p></sec><sec id="s4-20"><title>Metabolic phenotyping</title><p>Mice were fasted for 6 hr prior to glucose tolerance tests (GTTs). Baseline glucose levels at 0 min timepoint (fasting glucose) were measured from blood samples collected from tail bleeds using a glucometer (Bayer Healthcare LLC). D-Glucose was injected i.p. (0.75 g/kg body weight) and glucose levels were measured at 7, 15, 30, 60, 90, and 120 min timepoints after injection. For insulin tolerance tests (ITTs), the mice were fasted for 4 hr. Similar to GTTs, the baseline blood glucose levels were measured at 0 min timepoint and 15, 30, 60, 90, and 120 min timepoints post-injection (i.p.) of insulin (HumulinR, 1.25 U/kg body weight). Mouse body composition was performed as previously described (<xref ref-type="bibr" rid="bib94">Zhang et al., 2017</xref>).</p></sec><sec id="s4-21"><title>Statistics</title><p>Data are represented as mean ± s.e.m. Two-tail unpaired Student’s t-tests were used for comparison between two groups. For three or more groups, data were analyzed by one-way analysis of variance (ANOVA) and Tukey’s post hoc test. For time-series data in <xref ref-type="fig" rid="fig5">Figure 5</xref> between two groups, data were analyzed using a two-way ANOVA followed by Bonferroni post hoc test. For GTTs and ITTs, two-way ANOVA was used. A p-value&lt;0.05 was considered statistically significant. *, **, and *** represent a p-value less than 0.05, 0.01, and 0.001, respectively.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>RNA-Seq data presented herein were obtained at the Genomics Division of the Iowa Institute of Human Genetics. This work was supported by grants from the NIH/NHLBI R01 HL125436 (CEG), NIH/NHLBI 5R00HL125683, NIH/NIGMS R35 GM137976, Cancer Research Foundation Young Investigator Award (ANS), NIH NIDDK 1R01DK106009, the Roy J Carver Trust (RS), UIHC Center for Hypertension Research Pilot and Feasibility Grant, VA Merit Award I01BX005072 (RS), andKing Abdullah International Medical Research Center (KAIMRC) grant RA17-014-A (AA). We thank Dr. Rithwick Rajagopal for insightful reading of the manuscript.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Software, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Supervision, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Supervision, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Visualization, Methodology</p></fn><fn fn-type="con" id="con9"><p>Supervision, Methodology</p></fn><fn fn-type="con" id="con10"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con11"><p>Methodology</p></fn><fn fn-type="con" id="con12"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con13"><p>Methodology</p></fn><fn fn-type="con" id="con14"><p>Data curation, Formal analysis, Supervision, Methodology</p></fn><fn fn-type="con" id="con15"><p>Supervision, Methodology</p></fn><fn fn-type="con" id="con16"><p>Supervision, Methodology</p></fn><fn fn-type="con" id="con17"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Animal experimentation: This study was performed in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to the approved Institutional Animal Care and Use Committee (IACUC) protocols of Washington University in St. Louis (20180217) and the University of Iowa (1308148).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>RNA sequencing data of human umbilical vein endothelial cell (HUVEC) treated with Ad-sh<italic>Scr</italic> and Ad-sh<italic>Lrrc8a.</italic></title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61313-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Ingenuity pathway analysis.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-61313-supp2-v2.xls"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-61313-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>RNA sequencing data has been deposited in GEO under accession number GSE166989. All other data available as source data files.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Alghanem</surname><given-names>Af</given-names></name><name><surname>Abello</surname><given-names>J</given-names></name><name><surname>Maurer</surname><given-names>JM</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Ta</surname><given-names>C</given-names></name><name><surname>Gunasekar</surname><given-names>SK</given-names></name><name><surname>Fatima</surname><given-names>U</given-names></name><name><surname>Kang</surname><given-names>C</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Adeola</surname><given-names>O</given-names></name><name><surname>Riker</surname><given-names>M</given-names></name><name><surname>Elliott-Hudson</surname><given-names>M</given-names></name><name><surname>Minerath</surname><given-names>RA</given-names></name><name><surname>Grueter</surname><given-names>CE</given-names></name><name><surname>Mullins</surname><given-names>RF</given-names></name><name><surname>Stratman</surname><given-names>AN</given-names></name><name><surname>Sah</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>The SWELL1-LRRC8 complex regulates endothelial AKT-eNOS- mTOR signaling and vascular function</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE166989">GSE166989</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abascal</surname> <given-names>F</given-names></name><name><surname>Zardoya</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>LRRC8 proteins share a common ancestor with pannexins, and may form hexameric channels involved in cell-cell communication</article-title><source>BioEssays</source><volume>34</volume><fpage>551</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1002/bies.201100173</pub-id><pub-id pub-id-type="pmid">22532330</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname> <given-names>H</given-names></name><name><surname>Brittebo</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Proangiogenic effects of environmentally relevant levels of bisphenol A in human primary endothelial cells</article-title><source>Archives of Toxicology</source><volume>86</volume><fpage>465</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.1007/s00204-011-0766-2</pub-id><pub-id pub-id-type="pmid">22045264</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arcaro</surname> <given-names>G</given-names></name><name><surname>Zamboni</surname> <given-names>M</given-names></name><name><surname>Rossi</surname> <given-names>L</given-names></name><name><surname>Turcato</surname> <given-names>E</given-names></name><name><surname>Covi</surname> <given-names>G</given-names></name><name><surname>Armellini</surname> <given-names>F</given-names></name><name><surname>Bosello</surname> <given-names>O</given-names></name><name><surname>Lechi</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity</article-title><source>International Journal of Obesity</source><volume>23</volume><fpage>936</fpage><lpage>942</lpage><pub-id pub-id-type="doi">10.1038/sj.ijo.0801022</pub-id><pub-id pub-id-type="pmid">10490799</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barakat</surname> <given-names>AI</given-names></name><name><surname>Leaver</surname> <given-names>EV</given-names></name><name><surname>Pappone</surname> <given-names>PA</given-names></name><name><surname>Davies</surname> <given-names>PF</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>A flow-activated chloride-selective membrane current in vascular endothelial cells</article-title><source>Circulation Research</source><volume>85</volume><fpage>820</fpage><lpage>828</lpage><pub-id pub-id-type="doi">10.1161/01.RES.85.9.820</pub-id><pub-id pub-id-type="pmid">10532950</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barakat</surname> <given-names>AI</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Responsiveness of vascular endothelium to shear stress: potential role of ion channels and cellular cytoskeleton (review)</article-title><source>International Journal of Molecular Medicine</source><volume>4</volume><fpage>323</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.3892/ijmm.4.4.323</pub-id><pub-id pub-id-type="pmid">10493972</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname> <given-names>SE</given-names></name><name><surname>Gu</surname> <given-names>X</given-names></name><name><surname>Samuel</surname> <given-names>S</given-names></name><name><surname>Marcus</surname> <given-names>DM</given-names></name><name><surname>Bartoli</surname> <given-names>M</given-names></name><name><surname>Huang</surname> <given-names>PL</given-names></name><name><surname>Caldwell</surname> <given-names>RB</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><volume>42</volume><fpage>222</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">11133872</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browe</surname> <given-names>DM</given-names></name><name><surname>Baumgarten</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Stretch of beta 1 integrin activates an outwardly rectifying chloride current via FAK and src in rabbit ventricular myocytes</article-title><source>Journal of General Physiology</source><volume>122</volume><fpage>689</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1085/jgp.200308899</pub-id><pub-id pub-id-type="pmid">14610020</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browe</surname> <given-names>DM</given-names></name><name><surname>Baumgarten</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>EGFR kinase regulates volume-sensitive chloride current elicited by integrin stretch via PI-3K and NADPH oxidase in ventricular myocytes</article-title><source>Journal of General Physiology</source><volume>127</volume><fpage>237</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1085/jgp.200509366</pub-id><pub-id pub-id-type="pmid">16505146</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bugiardini</surname> <given-names>R</given-names></name><name><surname>Manfrini</surname> <given-names>O</given-names></name><name><surname>Pizzi</surname> <given-names>C</given-names></name><name><surname>Fontana</surname> <given-names>F</given-names></name><name><surname>Morgagni</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms</article-title><source>Circulation</source><volume>109</volume><fpage>2518</fpage><lpage>2523</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000128208.22378.E3</pub-id><pub-id pub-id-type="pmid">15136498</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cahill</surname> <given-names>PA</given-names></name><name><surname>Redmond</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Vascular endothelium - Gatekeeper of vessel health</article-title><source>Atherosclerosis</source><volume>248</volume><fpage>97</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2016.03.007</pub-id><pub-id pub-id-type="pmid">26994427</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cappelli</surname> <given-names>HC</given-names></name><name><surname>Kanugula</surname> <given-names>AK</given-names></name><name><surname>Adapala</surname> <given-names>RK</given-names></name><name><surname>Amin</surname> <given-names>V</given-names></name><name><surname>Sharma</surname> <given-names>P</given-names></name><name><surname>Midha</surname> <given-names>P</given-names></name><name><surname>Paruchuri</surname> <given-names>S</given-names></name><name><surname>Thodeti</surname> <given-names>CK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mechanosensitive TRPV4 channels stabilize VE-cadherin junctions to regulate tumor vascular integrity and metastasis</article-title><source>Cancer Letters</source><volume>442</volume><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2018.07.042</pub-id><pub-id pub-id-type="pmid">30401632</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clapp</surname> <given-names>BR</given-names></name><name><surname>Hingorani</surname> <given-names>AD</given-names></name><name><surname>Kharbanda</surname> <given-names>RK</given-names></name><name><surname>Mohamed-Ali</surname> <given-names>V</given-names></name><name><surname>Stephens</surname> <given-names>JW</given-names></name><name><surname>Vallance</surname> <given-names>P</given-names></name><name><surname>MacAllister</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress</article-title><source>Cardiovascular Research</source><volume>64</volume><fpage>172</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2004.06.020</pub-id><pub-id pub-id-type="pmid">15364625</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coste</surname> <given-names>B</given-names></name><name><surname>Mathur</surname> <given-names>J</given-names></name><name><surname>Schmidt</surname> <given-names>M</given-names></name><name><surname>Earley</surname> <given-names>TJ</given-names></name><name><surname>Ranade</surname> <given-names>S</given-names></name><name><surname>Petrus</surname> <given-names>MJ</given-names></name><name><surname>Dubin</surname> <given-names>AE</given-names></name><name><surname>Patapoutian</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels</article-title><source>Science</source><volume>330</volume><fpage>55</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1126/science.1193270</pub-id><pub-id pub-id-type="pmid">20813920</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coste</surname> <given-names>B</given-names></name><name><surname>Xiao</surname> <given-names>B</given-names></name><name><surname>Santos</surname> <given-names>JS</given-names></name><name><surname>Syeda</surname> <given-names>R</given-names></name><name><surname>Grandl</surname> <given-names>J</given-names></name><name><surname>Spencer</surname> <given-names>KS</given-names></name><name><surname>Kim</surname> <given-names>SE</given-names></name><name><surname>Schmidt</surname> <given-names>M</given-names></name><name><surname>Mathur</surname> <given-names>J</given-names></name><name><surname>Dubin</surname> <given-names>AE</given-names></name><name><surname>Montal</surname> <given-names>M</given-names></name><name><surname>Patapoutian</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Piezo proteins are pore-forming subunits of mechanically activated channels</article-title><source>Nature</source><volume>483</volume><fpage>176</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1038/nature10812</pub-id><pub-id pub-id-type="pmid">22343900</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalsgaard</surname> <given-names>T</given-names></name><name><surname>Sonkusare</surname> <given-names>SK</given-names></name><name><surname>Teuscher</surname> <given-names>C</given-names></name><name><surname>Poynter</surname> <given-names>ME</given-names></name><name><surname>Nelson</surname> <given-names>MT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Pharmacological inhibitors of TRPV4 channels reduce cytokine production, restore endothelial function and increase survival in septic mice</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>33841</elocation-id><pub-id pub-id-type="doi">10.1038/srep33841</pub-id><pub-id pub-id-type="pmid">27653046</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname> <given-names>Y</given-names></name><name><surname>Shan</surname> <given-names>L</given-names></name><name><surname>Nai</surname> <given-names>W</given-names></name><name><surname>Lin</surname> <given-names>X</given-names></name><name><surname>Zhou</surname> <given-names>L</given-names></name><name><surname>Dong</surname> <given-names>X</given-names></name><name><surname>Wu</surname> <given-names>H</given-names></name><name><surname>Xiao</surname> <given-names>M</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>T</given-names></name><name><surname>Fu</surname> <given-names>Y</given-names></name><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Jia</surname> <given-names>C</given-names></name><name><surname>Dai</surname> <given-names>M</given-names></name><name><surname>Bai</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>DEPTOR Deficiency-Mediated mTORc1 hyperactivation in vascular endothelial cells promotes angiogenesis</article-title><source>Cellular Physiology and Biochemistry</source><volume>46</volume><fpage>520</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1159/000488619</pub-id><pub-id pub-id-type="pmid">29614494</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname> <given-names>ER</given-names></name><name><surname>Crossey</surname> <given-names>PA</given-names></name><name><surname>Walker</surname> <given-names>S</given-names></name><name><surname>Anilkumar</surname> <given-names>N</given-names></name><name><surname>Poston</surname> <given-names>L</given-names></name><name><surname>Douglas</surname> <given-names>G</given-names></name><name><surname>Ezzat</surname> <given-names>VA</given-names></name><name><surname>Wheatcroft</surname> <given-names>SB</given-names></name><name><surname>Shah</surname> <given-names>AM</given-names></name><name><surname>Kearney</surname> <given-names>MT</given-names></name><name><surname>Kearney</surname> <given-names>MI</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Effect of endothelium-specific insulin resistance on endothelial function in vivo</article-title><source>Diabetes</source><volume>57</volume><fpage>3307</fpage><lpage>3314</lpage><pub-id pub-id-type="doi">10.2337/db07-1111</pub-id><pub-id pub-id-type="pmid">18835939</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname> <given-names>KM</given-names></name><name><surname>Hill-Eubanks</surname> <given-names>DC</given-names></name><name><surname>Liedtke</surname> <given-names>WB</given-names></name><name><surname>Nelson</surname> <given-names>MT</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>TRPV4 channels stimulate Ca2+-induced Ca2+ release in astrocytic endfeet and amplify neurovascular coupling responses</article-title><source>PNAS</source><volume>110</volume><fpage>6157</fpage><lpage>6162</lpage><pub-id pub-id-type="doi">10.1073/pnas.1216514110</pub-id><pub-id pub-id-type="pmid">23530219</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Earley</surname> <given-names>S</given-names></name><name><surname>Heppner</surname> <given-names>TJ</given-names></name><name><surname>Nelson</surname> <given-names>MT</given-names></name><name><surname>Brayden</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>TRPV4 forms a novel Ca2+ signaling complex with ryanodine receptors and BKCa channels</article-title><source>Circulation Research</source><volume>97</volume><fpage>1270</fpage><lpage>1279</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000194321.60300.d6</pub-id><pub-id pub-id-type="pmid">16269659</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Earley</surname> <given-names>S</given-names></name><name><surname>Pauyo</surname> <given-names>T</given-names></name><name><surname>Drapp</surname> <given-names>R</given-names></name><name><surname>Tavares</surname> <given-names>MJ</given-names></name><name><surname>Liedtke</surname> <given-names>W</given-names></name><name><surname>Brayden</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>TRPV4-dependent dilation of peripheral resistance arteries influences arterial pressure</article-title><source>American Journal of Physiology-Heart and Circulatory Physiology</source><volume>297</volume><fpage>H1096</fpage><lpage>H1102</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00241.2009</pub-id><pub-id pub-id-type="pmid">19617407</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egorov</surname> <given-names>YV</given-names></name><name><surname>Lang</surname> <given-names>D</given-names></name><name><surname>Tyan</surname> <given-names>L</given-names></name><name><surname>Turner</surname> <given-names>D</given-names></name><name><surname>Lim</surname> <given-names>E</given-names></name><name><surname>Piro</surname> <given-names>ZD</given-names></name><name><surname>Hernandez</surname> <given-names>JJ</given-names></name><name><surname>Lodin</surname> <given-names>R</given-names></name><name><surname>Wang</surname> <given-names>R</given-names></name><name><surname>Schmuck</surname> <given-names>EG</given-names></name><name><surname>Raval</surname> <given-names>AN</given-names></name><name><surname>Ralphe</surname> <given-names>CJ</given-names></name><name><surname>Kamp</surname> <given-names>TJ</given-names></name><name><surname>Rosenshtraukh</surname> <given-names>LV</given-names></name><name><surname>Glukhov</surname> <given-names>AV</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Caveolae-Mediated activation of mechanosensitive chloride channels in pulmonary veins triggers atrial arrhythmogenesis</article-title><source>Journal of the American Heart Association</source><volume>8</volume><elocation-id>e012748</elocation-id><pub-id pub-id-type="doi">10.1161/JAHA.119.012748</pub-id><pub-id pub-id-type="pmid">31597508</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname> <given-names>Y</given-names></name><name><surname>Venema</surname> <given-names>VJ</given-names></name><name><surname>Venema</surname> <given-names>RC</given-names></name><name><surname>Tsai</surname> <given-names>N</given-names></name><name><surname>Caldwell</surname> <given-names>RB</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells</article-title><source>Biochemical and Biophysical Research Communications</source><volume>256</volume><fpage>192</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1998.9790</pub-id><pub-id pub-id-type="pmid">10066445</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulton</surname> <given-names>D</given-names></name><name><surname>Fontana</surname> <given-names>J</given-names></name><name><surname>Sowa</surname> <given-names>G</given-names></name><name><surname>Gratton</surname> <given-names>J-P</given-names></name><name><surname>Lin</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>K-X</given-names></name><name><surname>Michell</surname> <given-names>B</given-names></name><name><surname>Kemp</surname> <given-names>BE</given-names></name><name><surname>Rodman</surname> <given-names>D</given-names></name><name><surname>Sessa</surname> <given-names>WC</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Localization of endothelial Nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in golgi and plasma membrane defines the existence of two pools of active enzyme</article-title><source>Journal of Biological Chemistry</source><volume>277</volume><fpage>4277</fpage><lpage>4284</lpage><pub-id pub-id-type="doi">10.1074/jbc.M106302200</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerhold</surname> <given-names>KA</given-names></name><name><surname>Schwartz</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ion channels in endothelial responses to fluid shear stress</article-title><source>Physiology</source><volume>31</volume><fpage>359</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1152/physiol.00007.2016</pub-id><pub-id pub-id-type="pmid">27511462</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gobeil</surname> <given-names>F</given-names></name><name><surname>Zhu</surname> <given-names>T</given-names></name><name><surname>Brault</surname> <given-names>S</given-names></name><name><surname>Geha</surname> <given-names>A</given-names></name><name><surname>Vazquez-Tello</surname> <given-names>A</given-names></name><name><surname>Fortier</surname> <given-names>A</given-names></name><name><surname>Barbaz</surname> <given-names>D</given-names></name><name><surname>Checchin</surname> <given-names>D</given-names></name><name><surname>Hou</surname> <given-names>X</given-names></name><name><surname>Nader</surname> <given-names>M</given-names></name><name><surname>Bkaily</surname> <given-names>G</given-names></name><name><surname>Gratton</surname> <given-names>JP</given-names></name><name><surname>Heveker</surname> <given-names>N</given-names></name><name><surname>Ribeiro-da-Silva</surname> <given-names>A</given-names></name><name><surname>Peri</surname> <given-names>K</given-names></name><name><surname>Bard</surname> <given-names>H</given-names></name><name><surname>Chorvatova</surname> <given-names>A</given-names></name><name><surname>D'Orléans-Juste</surname> <given-names>P</given-names></name><name><surname>Goetzl</surname> <given-names>EJ</given-names></name><name><surname>Chemtob</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Nitric oxide signaling via nuclearized endothelial nitric-oxide synthase modulates expression of the immediate early genes iNOS and mPGES-1</article-title><source>Journal of Biological Chemistry</source><volume>281</volume><fpage>16058</fpage><lpage>16067</lpage><pub-id pub-id-type="doi">10.1074/jbc.M602219200</pub-id><pub-id pub-id-type="pmid">16574649</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goettsch</surname> <given-names>C</given-names></name><name><surname>Goettsch</surname> <given-names>W</given-names></name><name><surname>Arsov</surname> <given-names>A</given-names></name><name><surname>Hofbauer</surname> <given-names>LC</given-names></name><name><surname>Bornstein</surname> <given-names>SR</given-names></name><name><surname>Morawietz</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Long-term cyclic strain downregulates endothelial Nox4</article-title><source>Antioxidants &amp; Redox Signaling</source><volume>11</volume><fpage>2385</fpage><lpage>2397</lpage><pub-id pub-id-type="doi">10.1089/ars.2009.2561</pub-id><pub-id pub-id-type="pmid">19309265</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goligorsky</surname> <given-names>MS</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Brodsky</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Relationships between caveolae and eNOS: everything in proximity and the proximity of everything</article-title><source>American Journal of Physiology-Renal Physiology</source><volume>283</volume><fpage>F1</fpage><lpage>F10</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00377.2001</pub-id><pub-id pub-id-type="pmid">12060581</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunasekar</surname> <given-names>SK</given-names></name><name><surname>Xie</surname> <given-names>L</given-names></name><name><surname>Sah</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>SWELL signalling in adipocytes: can fat 'feel' fat?</article-title><source>Adipocyte</source><volume>8</volume><fpage>223</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1080/21623945.2019.1612223</pub-id><pub-id pub-id-type="pmid">31112068</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harb</surname> <given-names>D</given-names></name><name><surname>Bujold</surname> <given-names>K</given-names></name><name><surname>Febbraio</surname> <given-names>M</given-names></name><name><surname>Sirois</surname> <given-names>MG</given-names></name><name><surname>Ong</surname> <given-names>H</given-names></name><name><surname>Marleau</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation</article-title><source>Cardiovascular Research</source><volume>83</volume><fpage>42</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvp081</pub-id><pub-id pub-id-type="pmid">19264766</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harraz</surname> <given-names>OF</given-names></name><name><surname>Longden</surname> <given-names>TA</given-names></name><name><surname>Hill-Eubanks</surname> <given-names>D</given-names></name><name><surname>Nelson</surname> <given-names>MT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>PIP2 depletion promotes TRPV4 channel activity in mouse brain capillary endothelial cells</article-title><source>eLife</source><volume>7</volume><elocation-id>e38689</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.38689</pub-id><pub-id pub-id-type="pmid">30084828</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname> <given-names>HJ</given-names></name><name><surname>Lee</surname> <given-names>CF</given-names></name><name><surname>Locke</surname> <given-names>A</given-names></name><name><surname>Vanderzyl</surname> <given-names>SQ</given-names></name><name><surname>Kaunas</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Stretch-induced stress fiber remodeling and the activations of JNK and ERK depend on mechanical strain rate, but not FAK</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e12470</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0012470</pub-id><pub-id pub-id-type="pmid">20814573</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>Z</given-names></name><name><surname>Xiong</surname> <given-names>Y</given-names></name><name><surname>Han</surname> <given-names>X</given-names></name><name><surname>Geng</surname> <given-names>C</given-names></name><name><surname>Jiang</surname> <given-names>B</given-names></name><name><surname>Huo</surname> <given-names>Y</given-names></name><name><surname>Luo</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Acute mechanical stretch promotes eNOS activation in venous endothelial cells mainly via PKA and akt pathways</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e71359</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0071359</pub-id><pub-id pub-id-type="pmid">23977025</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janus</surname> <given-names>A</given-names></name><name><surname>Szahidewicz-Krupska</surname> <given-names>E</given-names></name><name><surname>Mazur</surname> <given-names>G</given-names></name><name><surname>Doroszko</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Insulin resistance and endothelial dysfunction constitute a common therapeutic target in cardiometabolic disorders</article-title><source>Mediators of Inflammation</source><volume>2016</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1155/2016/3634948</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ju</surname> <given-names>H</given-names></name><name><surname>Zou</surname> <given-names>R</given-names></name><name><surname>Venema</surname> <given-names>VJ</given-names></name><name><surname>Venema</surname> <given-names>RC</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity</article-title><source>Journal of Biological Chemistry</source><volume>272</volume><fpage>18522</fpage><lpage>18525</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.30.18522</pub-id><pub-id pub-id-type="pmid">9228013</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jufri</surname> <given-names>NF</given-names></name><name><surname>Mohamedali</surname> <given-names>A</given-names></name><name><surname>Avolio</surname> <given-names>A</given-names></name><name><surname>Baker</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mechanical stretch: physiological and pathological implications for human vascular endothelial cells</article-title><source>Vascular Cell</source><volume>7</volume><elocation-id>8</elocation-id><pub-id pub-id-type="doi">10.1186/s13221-015-0033-z</pub-id><pub-id pub-id-type="pmid">26388991</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>C</given-names></name><name><surname>Xie</surname> <given-names>L</given-names></name><name><surname>Gunasekar</surname> <given-names>SK</given-names></name><name><surname>Mishra</surname> <given-names>A</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Pai</surname> <given-names>S</given-names></name><name><surname>Gao</surname> <given-names>Y</given-names></name><name><surname>Kumar</surname> <given-names>A</given-names></name><name><surname>Norris</surname> <given-names>AW</given-names></name><name><surname>Stephens</surname> <given-names>SB</given-names></name><name><surname>Sah</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>SWELL1 is a glucose sensor regulating ß-cell excitability and systemic glycaemia</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>367</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-02664-0</pub-id><pub-id pub-id-type="pmid">29371604</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kataoka</surname> <given-names>C</given-names></name><name><surname>Egashira</surname> <given-names>K</given-names></name><name><surname>Inoue</surname> <given-names>S</given-names></name><name><surname>Takemoto</surname> <given-names>M</given-names></name><name><surname>Ni</surname> <given-names>W</given-names></name><name><surname>Koyanagi</surname> <given-names>M</given-names></name><name><surname>Kitamoto</surname> <given-names>S</given-names></name><name><surname>Usui</surname> <given-names>M</given-names></name><name><surname>Kaibuchi</surname> <given-names>K</given-names></name><name><surname>Shimokawa</surname> <given-names>H</given-names></name><name><surname>Takeshita</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats</article-title><source>Hypertension</source><volume>39</volume><fpage>245</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1161/hy0202.103271</pub-id><pub-id pub-id-type="pmid">11847192</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearney</surname> <given-names>MT</given-names></name><name><surname>Duncan</surname> <given-names>ER</given-names></name><name><surname>Kahn</surname> <given-names>M</given-names></name><name><surname>Wheatcroft</surname> <given-names>SB</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Insulin resistance and endothelial cell dysfunction: studies in mammalian models</article-title><source>Experimental Physiology</source><volume>93</volume><fpage>158</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1113/expphysiol.2007.039172</pub-id><pub-id pub-id-type="pmid">17933859</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname> <given-names>DJ</given-names></name><name><surname>Kuchibhotla</surname> <given-names>SD</given-names></name><name><surname>Guy</surname> <given-names>E</given-names></name><name><surname>Park</surname> <given-names>YM</given-names></name><name><surname>Nimako</surname> <given-names>G</given-names></name><name><surname>Vanegas</surname> <given-names>D</given-names></name><name><surname>Morton</surname> <given-names>RE</given-names></name><name><surname>Febbraio</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Dietary cholesterol plays a role in CD36-mediated atherogenesis in LDLR-knockout mice</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>29</volume><fpage>1481</fpage><lpage>1487</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.109.191940</pub-id><pub-id pub-id-type="pmid">19608973</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname> <given-names>W</given-names></name><name><surname>Stratman</surname> <given-names>AN</given-names></name><name><surname>Sacharidou</surname> <given-names>A</given-names></name><name><surname>Davis</surname> <given-names>GE</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>In vitro three dimensional collagen matrix models of endothelial lumen formation during vasculogenesis and angiogenesis</article-title><source>Methods in Enzymology</source><volume>443</volume><fpage>83</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/S0076-6879(08)02005-3</pub-id><pub-id pub-id-type="pmid">18772012</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname> <given-names>T</given-names></name><name><surname>Vicent</surname> <given-names>D</given-names></name><name><surname>Suzuma</surname> <given-names>K</given-names></name><name><surname>Yanagisawa</surname> <given-names>M</given-names></name><name><surname>King</surname> <given-names>GL</given-names></name><name><surname>Holzenberger</surname> <given-names>M</given-names></name><name><surname>Kahn</surname> <given-names>CR</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization</article-title><source>Journal of Clinical Investigation</source><volume>111</volume><fpage>1835</fpage><lpage>1842</lpage><pub-id pub-id-type="doi">10.1172/JCI200317455</pub-id><pub-id pub-id-type="pmid">12813019</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubota</surname> <given-names>K</given-names></name><name><surname>Kim</surname> <given-names>JY</given-names></name><name><surname>Sawada</surname> <given-names>A</given-names></name><name><surname>Tokimasa</surname> <given-names>S</given-names></name><name><surname>Fujisaki</surname> <given-names>H</given-names></name><name><surname>Matsuda-Hashii</surname> <given-names>Y</given-names></name><name><surname>Ozono</surname> <given-names>K</given-names></name><name><surname>Hara</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>LRRC8 involved in B cell development belongs to a novel family of leucine-rich repeat proteins</article-title><source>FEBS Letters</source><volume>564</volume><fpage>147</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(04)00332-1</pub-id><pub-id pub-id-type="pmid">15094057</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>L</given-names></name><name><surname>Chou</surname> <given-names>J</given-names></name><name><surname>Yee</surname> <given-names>CS</given-names></name><name><surname>Borzutzky</surname> <given-names>A</given-names></name><name><surname>Vollmann</surname> <given-names>EH</given-names></name><name><surname>von Andrian</surname> <given-names>UH</given-names></name><name><surname>Park</surname> <given-names>SY</given-names></name><name><surname>Hollander</surname> <given-names>G</given-names></name><name><surname>Manis</surname> <given-names>JP</given-names></name><name><surname>Poliani</surname> <given-names>PL</given-names></name><name><surname>Geha</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Leucine-rich repeat containing 8A (LRRC8A) is essential for T lymphocyte development and function</article-title><source>Journal of Experimental Medicine</source><volume>211</volume><fpage>929</fpage><lpage>942</lpage><pub-id pub-id-type="doi">10.1084/jem.20131379</pub-id><pub-id pub-id-type="pmid">24752297</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>A</given-names></name><name><surname>Xie</surname> <given-names>L</given-names></name><name><surname>Ta</surname> <given-names>CM</given-names></name><name><surname>Hinton</surname> <given-names>AO</given-names></name><name><surname>Gunasekar</surname> <given-names>SK</given-names></name><name><surname>Minerath</surname> <given-names>RA</given-names></name><name><surname>Shen</surname> <given-names>K</given-names></name><name><surname>Maurer</surname> <given-names>JM</given-names></name><name><surname>Grueter</surname> <given-names>CE</given-names></name><name><surname>Abel</surname> <given-names>ED</given-names></name><name><surname>Meyer</surname> <given-names>G</given-names></name><name><surname>Sah</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SWELL1 regulates skeletal muscle cell size, intracellular signaling, adiposity and glucose metabolism</article-title><source>eLife</source><volume>9</volume><elocation-id>e58941</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.58941</pub-id><pub-id pub-id-type="pmid">32930093</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Hou</surname> <given-names>B</given-names></name><name><surname>Tumova</surname> <given-names>S</given-names></name><name><surname>Muraki</surname> <given-names>K</given-names></name><name><surname>Bruns</surname> <given-names>A</given-names></name><name><surname>Ludlow</surname> <given-names>MJ</given-names></name><name><surname>Sedo</surname> <given-names>A</given-names></name><name><surname>Hyman</surname> <given-names>AJ</given-names></name><name><surname>McKeown</surname> <given-names>L</given-names></name><name><surname>Young</surname> <given-names>RS</given-names></name><name><surname>Yuldasheva</surname> <given-names>NY</given-names></name><name><surname>Majeed</surname> <given-names>Y</given-names></name><name><surname>Wilson</surname> <given-names>LA</given-names></name><name><surname>Rode</surname> <given-names>B</given-names></name><name><surname>Bailey</surname> <given-names>MA</given-names></name><name><surname>Kim</surname> <given-names>HR</given-names></name><name><surname>Fu</surname> <given-names>Z</given-names></name><name><surname>Carter</surname> <given-names>DA</given-names></name><name><surname>Bilton</surname> <given-names>J</given-names></name><name><surname>Imrie</surname> <given-names>H</given-names></name><name><surname>Ajuh</surname> <given-names>P</given-names></name><name><surname>Dear</surname> <given-names>TN</given-names></name><name><surname>Cubbon</surname> <given-names>RM</given-names></name><name><surname>Kearney</surname> <given-names>MT</given-names></name><name><surname>Prasad</surname> <given-names>RK</given-names></name><name><surname>Evans</surname> <given-names>PC</given-names></name><name><surname>Ainscough</surname> <given-names>JF</given-names></name><name><surname>Beech</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Piezo1 integration of vascular architecture with physiological force</article-title><source>Nature</source><volume>515</volume><fpage>279</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1038/nature13701</pub-id><pub-id pub-id-type="pmid">25119035</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>XM</given-names></name><name><surname>Ensenat</surname> <given-names>D</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Schafer</surname> <given-names>AI</given-names></name><name><surname>Durante</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Physiologic cyclic stretch inhibits apoptosis in vascular endothelium</article-title><source>FEBS Letters</source><volume>541</volume><fpage>52</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(03)00285-0</pub-id><pub-id pub-id-type="pmid">12706818</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lück</surname> <given-names>JC</given-names></name><name><surname>Puchkov</surname> <given-names>D</given-names></name><name><surname>Ullrich</surname> <given-names>F</given-names></name><name><surname>Jentsch</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>LRRC8/VRAC anion channels are required for late stages of spermatid development in mice</article-title><source>Journal of Biological Chemistry</source><volume>293</volume><fpage>11796</fpage><lpage>11808</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA118.003853</pub-id><pub-id pub-id-type="pmid">29880644</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendoza</surname> <given-names>SA</given-names></name><name><surname>Fang</surname> <given-names>J</given-names></name><name><surname>Gutterman</surname> <given-names>DD</given-names></name><name><surname>Wilcox</surname> <given-names>DA</given-names></name><name><surname>Bubolz</surname> <given-names>AH</given-names></name><name><surname>Li</surname> <given-names>R</given-names></name><name><surname>Suzuki</surname> <given-names>M</given-names></name><name><surname>Zhang</surname> <given-names>DX</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>TRPV4-mediated endothelial Ca2+ influx and vasodilation in response to shear stress</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>298</volume><fpage>466</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00854.2009</pub-id><pub-id pub-id-type="pmid">19966050</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercado</surname> <given-names>J</given-names></name><name><surname>Baylie</surname> <given-names>R</given-names></name><name><surname>Navedo</surname> <given-names>MF</given-names></name><name><surname>Yuan</surname> <given-names>C</given-names></name><name><surname>Scott</surname> <given-names>JD</given-names></name><name><surname>Nelson</surname> <given-names>MT</given-names></name><name><surname>Brayden</surname> <given-names>JE</given-names></name><name><surname>Santana</surname> <given-names>LF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Local control of TRPV4 channels by AKAP150-targeted PKC in arterial smooth muscle</article-title><source>Journal of General Physiology</source><volume>143</volume><fpage>559</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1085/jgp.201311050</pub-id><pub-id pub-id-type="pmid">24778429</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montagnani</surname> <given-names>M</given-names></name><name><surname>Ravichandran</surname> <given-names>LV</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Esposito</surname> <given-names>DL</given-names></name><name><surname>Quon</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells</article-title><source>Molecular Endocrinology</source><volume>16</volume><fpage>1931</fpage><lpage>1942</lpage><pub-id pub-id-type="doi">10.1210/me.2002-0074</pub-id><pub-id pub-id-type="pmid">12145346</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morello</surname> <given-names>F</given-names></name><name><surname>Perino</surname> <given-names>A</given-names></name><name><surname>Hirsch</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Phosphoinositide 3-kinase signalling in the vascular system</article-title><source>Cardiovascular Research</source><volume>82</volume><fpage>261</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvn325</pub-id><pub-id pub-id-type="pmid">19038971</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muniyappa</surname> <given-names>R</given-names></name><name><surname>Sowers</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Role of insulin resistance in endothelial dysfunction</article-title><source>Reviews in Endocrine and Metabolic Disorders</source><volume>14</volume><fpage>5</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1007/s11154-012-9229-1</pub-id><pub-id pub-id-type="pmid">23306778</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname> <given-names>C</given-names></name><name><surname>Kanaganayagam</surname> <given-names>GS</given-names></name><name><surname>Jiang</surname> <given-names>B</given-names></name><name><surname>Chowienczyk</surname> <given-names>PJ</given-names></name><name><surname>Zbinden</surname> <given-names>R</given-names></name><name><surname>Saha</surname> <given-names>M</given-names></name><name><surname>Rahman</surname> <given-names>S</given-names></name><name><surname>Shah</surname> <given-names>AM</given-names></name><name><surname>Marber</surname> <given-names>MS</given-names></name><name><surname>Kearney</surname> <given-names>MT</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK south asian men</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>27</volume><fpage>936</fpage><lpage>942</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.0000258788.11372.d0</pub-id><pub-id pub-id-type="pmid">17255539</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakao</surname> <given-names>M</given-names></name><name><surname>Ono</surname> <given-names>K</given-names></name><name><surname>Fujisawa</surname> <given-names>S</given-names></name><name><surname>Iijima</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Mechanical stress-induced Ca2+ entry and cl- current in cultured human aortic endothelial cells</article-title><source>The American Journal of Physiology</source><volume>276</volume><fpage>238</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.1999.276.1.C238</pub-id><pub-id pub-id-type="pmid">9886940</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nassoy</surname> <given-names>P</given-names></name><name><surname>Lamaze</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Stressing caveolae new role in cell mechanics</article-title><source>Trends in Cell Biology</source><volume>22</volume><fpage>381</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2012.04.007</pub-id><pub-id pub-id-type="pmid">22613354</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilius</surname> <given-names>B</given-names></name><name><surname>Droogmans</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Ion channels and their functional role in vascular endothelium</article-title><source>Physiological Reviews</source><volume>81</volume><fpage>1415</fpage><lpage>1459</lpage><pub-id pub-id-type="doi">10.1152/physrev.2001.81.4.1415</pub-id><pub-id pub-id-type="pmid">11581493</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname> <given-names>RM</given-names></name><name><surname>Ferrige</surname> <given-names>AG</given-names></name><name><surname>Moncada</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor</article-title><source>Nature</source><volume>327</volume><fpage>524</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1038/327524a0</pub-id><pub-id pub-id-type="pmid">3495737</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>YM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>CD36, a scavenger receptor implicated in atherosclerosis</article-title><source>Experimental &amp; Molecular Medicine</source><volume>46</volume><elocation-id>e99</elocation-id><pub-id pub-id-type="doi">10.1038/emm.2014.38</pub-id><pub-id pub-id-type="pmid">24903227</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname> <given-names>Z</given-names></name><name><surname>Dubin</surname> <given-names>AE</given-names></name><name><surname>Mathur</surname> <given-names>J</given-names></name><name><surname>Tu</surname> <given-names>B</given-names></name><name><surname>Reddy</surname> <given-names>K</given-names></name><name><surname>Miraglia</surname> <given-names>LJ</given-names></name><name><surname>Reinhardt</surname> <given-names>J</given-names></name><name><surname>Orth</surname> <given-names>AP</given-names></name><name><surname>Patapoutian</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>SWELL1, a plasma membrane protein, is an essential component of volume-regulated anion channel</article-title><source>Cell</source><volume>157</volume><fpage>447</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.03.024</pub-id><pub-id pub-id-type="pmid">24725410</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quillon</surname> <given-names>A</given-names></name><name><surname>Fromy</surname> <given-names>B</given-names></name><name><surname>Debret</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Endothelium microenvironment sensing leading to nitric oxide mediated vasodilation: a review of nervous and biomechanical signals</article-title><source>Nitric Oxide</source><volume>45</volume><fpage>20</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.niox.2015.01.006</pub-id><pub-id pub-id-type="pmid">25638487</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radomski</surname> <given-names>MW</given-names></name><name><surname>Palmer</surname> <given-names>RM</given-names></name><name><surname>Moncada</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1987">1987a</year><article-title>The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium</article-title><source>Biochemical and Biophysical Research Communications</source><volume>148</volume><fpage>1482</fpage><lpage>1489</lpage><pub-id pub-id-type="doi">10.1016/S0006-291X(87)80299-1</pub-id><pub-id pub-id-type="pmid">2825688</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radomski</surname> <given-names>MW</given-names></name><name><surname>Palmer</surname> <given-names>RM</given-names></name><name><surname>Moncada</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1987">1987b</year><article-title>Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium</article-title><source>The Lancet</source><volume>2</volume><fpage>1057</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(87)91481-4</pub-id><pub-id pub-id-type="pmid">2889967</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rode</surname> <given-names>B</given-names></name><name><surname>Shi</surname> <given-names>J</given-names></name><name><surname>Endesh</surname> <given-names>N</given-names></name><name><surname>Drinkhill</surname> <given-names>MJ</given-names></name><name><surname>Webster</surname> <given-names>PJ</given-names></name><name><surname>Lotteau</surname> <given-names>SJ</given-names></name><name><surname>Bailey</surname> <given-names>MA</given-names></name><name><surname>Yuldasheva</surname> <given-names>NY</given-names></name><name><surname>Ludlow</surname> <given-names>MJ</given-names></name><name><surname>Cubbon</surname> <given-names>RM</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Futers</surname> <given-names>TS</given-names></name><name><surname>Morley</surname> <given-names>L</given-names></name><name><surname>Gaunt</surname> <given-names>HJ</given-names></name><name><surname>Marszalek</surname> <given-names>K</given-names></name><name><surname>Viswambharan</surname> <given-names>H</given-names></name><name><surname>Cuthbertson</surname> <given-names>K</given-names></name><name><surname>Baxter</surname> <given-names>PD</given-names></name><name><surname>Foster</surname> <given-names>R</given-names></name><name><surname>Sukumar</surname> <given-names>P</given-names></name><name><surname>Weightman</surname> <given-names>A</given-names></name><name><surname>Calaghan</surname> <given-names>SC</given-names></name><name><surname>Wheatcroft</surname> <given-names>SB</given-names></name><name><surname>Kearney</surname> <given-names>MT</given-names></name><name><surname>Beech</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Piezo1 channels sense whole body physical activity to reset cardiovascular homeostasis and enhance performance</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>350</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-00429-3</pub-id><pub-id pub-id-type="pmid">28839146</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romanenko</surname> <given-names>VG</given-names></name><name><surname>Davies</surname> <given-names>PF</given-names></name><name><surname>Levitan</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Dual effect of fluid shear stress on volume-regulated anion current in bovine aortic endothelial cells</article-title><source>American Journal of Physiology-Cell Physiology</source><volume>282</volume><fpage>C708</fpage><lpage>C718</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00247.2001</pub-id><pub-id pub-id-type="pmid">11880259</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salameh</surname> <given-names>A</given-names></name><name><surname>Galvagni</surname> <given-names>F</given-names></name><name><surname>Bardelli</surname> <given-names>M</given-names></name><name><surname>Bussolino</surname> <given-names>F</given-names></name><name><surname>Oliviero</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways</article-title><source>Blood</source><volume>106</volume><fpage>3423</fpage><lpage>3431</lpage><pub-id pub-id-type="doi">10.1182/blood-2005-04-1388</pub-id><pub-id pub-id-type="pmid">16076871</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawada</surname> <given-names>A</given-names></name><name><surname>Takihara</surname> <given-names>Y</given-names></name><name><surname>Kim</surname> <given-names>JY</given-names></name><name><surname>Matsuda-Hashii</surname> <given-names>Y</given-names></name><name><surname>Tokimasa</surname> <given-names>S</given-names></name><name><surname>Fujisaki</surname> <given-names>H</given-names></name><name><surname>Kubota</surname> <given-names>K</given-names></name><name><surname>Endo</surname> <given-names>H</given-names></name><name><surname>Onodera</surname> <given-names>T</given-names></name><name><surname>Ohta</surname> <given-names>H</given-names></name><name><surname>Ozono</surname> <given-names>K</given-names></name><name><surname>Hara</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humans</article-title><source>Journal of Clinical Investigation</source><volume>112</volume><fpage>1707</fpage><lpage>1713</lpage><pub-id pub-id-type="doi">10.1172/JCI18937</pub-id><pub-id pub-id-type="pmid">14660746</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schächinger</surname> <given-names>V</given-names></name><name><surname>Britten</surname> <given-names>MB</given-names></name><name><surname>Zeiher</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease</article-title><source>Circulation</source><volume>101</volume><fpage>1899</fpage><lpage>1906</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.101.16.1899</pub-id><pub-id pub-id-type="pmid">10779454</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schäfer</surname> <given-names>A</given-names></name><name><surname>Widder</surname> <given-names>J</given-names></name><name><surname>Eigenthaler</surname> <given-names>M</given-names></name><name><surname>Ertl</surname> <given-names>G</given-names></name><name><surname>Bauersachs</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2004">2004a</year><article-title>Reduced basal nitric oxide bioavailability and platelet activation in young spontaneously hypertensive rats</article-title><source>Biochemical Pharmacology</source><volume>67</volume><fpage>2273</fpage><lpage>2279</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2004.02.034</pub-id><pub-id pub-id-type="pmid">15163558</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schäfer</surname> <given-names>A</given-names></name><name><surname>Wiesmann</surname> <given-names>F</given-names></name><name><surname>Neubauer</surname> <given-names>S</given-names></name><name><surname>Eigenthaler</surname> <given-names>M</given-names></name><name><surname>Bauersachs</surname> <given-names>J</given-names></name><name><surname>Channon</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2004">2004b</year><article-title>Rapid regulation of platelet activation in vivo by nitric oxide</article-title><source>Circulation</source><volume>109</volume><fpage>1819</fpage><lpage>1822</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000126837.88743.DD</pub-id><pub-id pub-id-type="pmid">15066953</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname> <given-names>J</given-names></name><name><surname>Arganda-Carreras</surname> <given-names>I</given-names></name><name><surname>Frise</surname> <given-names>E</given-names></name><name><surname>Kaynig</surname> <given-names>V</given-names></name><name><surname>Longair</surname> <given-names>M</given-names></name><name><surname>Pietzsch</surname> <given-names>T</given-names></name><name><surname>Preibisch</surname> <given-names>S</given-names></name><name><surname>Rueden</surname> <given-names>C</given-names></name><name><surname>Saalfeld</surname> <given-names>S</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Tinevez</surname> <given-names>JY</given-names></name><name><surname>White</surname> <given-names>DJ</given-names></name><name><surname>Hartenstein</surname> <given-names>V</given-names></name><name><surname>Eliceiri</surname> <given-names>K</given-names></name><name><surname>Tomancak</surname> <given-names>P</given-names></name><name><surname>Cardona</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sedding</surname> <given-names>DG</given-names></name><name><surname>Hermsen</surname> <given-names>J</given-names></name><name><surname>Seay</surname> <given-names>U</given-names></name><name><surname>Eickelberg</surname> <given-names>O</given-names></name><name><surname>Kummer</surname> <given-names>W</given-names></name><name><surname>Schwencke</surname> <given-names>C</given-names></name><name><surname>Strasser</surname> <given-names>RH</given-names></name><name><surname>Tillmanns</surname> <given-names>H</given-names></name><name><surname>Braun-Dullaeus</surname> <given-names>RC</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo</article-title><source>Circulation Research</source><volume>96</volume><fpage>635</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000160610.61306.0f</pub-id><pub-id pub-id-type="pmid">15731459</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>F</given-names></name><name><surname>Chiu</surname> <given-names>YJ</given-names></name><name><surname>Cho</surname> <given-names>Y</given-names></name><name><surname>Bullard</surname> <given-names>TA</given-names></name><name><surname>Sokabe</surname> <given-names>M</given-names></name><name><surname>Fujiwara</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Down-regulation of ERK but not MEK phosphorylation in cultured endothelial cells by repeated changes in cyclic stretch</article-title><source>Cardiovascular Research</source><volume>73</volume><fpage>813</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2006.12.014</pub-id><pub-id pub-id-type="pmid">17289004</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverstein</surname> <given-names>RL</given-names></name><name><surname>Febbraio</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior</article-title><source>Science Signaling</source><volume>2</volume><elocation-id>re3</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.272re3</pub-id><pub-id pub-id-type="pmid">19471024</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname> <given-names>B</given-names></name><name><surname>Köster</surname> <given-names>D</given-names></name><name><surname>Ruez</surname> <given-names>R</given-names></name><name><surname>Gonnord</surname> <given-names>P</given-names></name><name><surname>Bastiani</surname> <given-names>M</given-names></name><name><surname>Abankwa</surname> <given-names>D</given-names></name><name><surname>Stan</surname> <given-names>RV</given-names></name><name><surname>Butler-Browne</surname> <given-names>G</given-names></name><name><surname>Vedie</surname> <given-names>B</given-names></name><name><surname>Johannes</surname> <given-names>L</given-names></name><name><surname>Morone</surname> <given-names>N</given-names></name><name><surname>Parton</surname> <given-names>RG</given-names></name><name><surname>Raposo</surname> <given-names>G</given-names></name><name><surname>Sens</surname> <given-names>P</given-names></name><name><surname>Lamaze</surname> <given-names>C</given-names></name><name><surname>Nassoy</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cells respond to mechanical stress by rapid disassembly of caveolae</article-title><source>Cell</source><volume>144</volume><fpage>402</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.12.031</pub-id><pub-id pub-id-type="pmid">21295700</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonkusare</surname> <given-names>SK</given-names></name><name><surname>Bonev</surname> <given-names>AD</given-names></name><name><surname>Ledoux</surname> <given-names>J</given-names></name><name><surname>Liedtke</surname> <given-names>W</given-names></name><name><surname>Kotlikoff</surname> <given-names>MI</given-names></name><name><surname>Heppner</surname> <given-names>TJ</given-names></name><name><surname>Hill-Eubanks</surname> <given-names>DC</given-names></name><name><surname>Nelson</surname> <given-names>MT</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Elementary Ca2+ signals through endothelial TRPV4 channels regulate vascular function</article-title><source>Science</source><volume>336</volume><fpage>597</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1126/science.1216283</pub-id><pub-id pub-id-type="pmid">22556255</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonkusare</surname> <given-names>SK</given-names></name><name><surname>Dalsgaard</surname> <given-names>T</given-names></name><name><surname>Bonev</surname> <given-names>AD</given-names></name><name><surname>Hill-Eubanks</surname> <given-names>DC</given-names></name><name><surname>Kotlikoff</surname> <given-names>MI</given-names></name><name><surname>Scott</surname> <given-names>JD</given-names></name><name><surname>Santana</surname> <given-names>LF</given-names></name><name><surname>Nelson</surname> <given-names>MT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>AKAP150-dependent cooperative TRPV4 channel gating is central to endothelium-dependent vasodilation and is disrupted in hypertension</article-title><source>Science Signaling</source><volume>7</volume><elocation-id>ra66</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2005052</pub-id><pub-id pub-id-type="pmid">25005230</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinberg</surname> <given-names>HO</given-names></name><name><surname>Chaker</surname> <given-names>H</given-names></name><name><surname>Leaming</surname> <given-names>R</given-names></name><name><surname>Johnson</surname> <given-names>A</given-names></name><name><surname>Brechtel</surname> <given-names>G</given-names></name><name><surname>Baron</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance</article-title><source>Journal of Clinical Investigation</source><volume>97</volume><fpage>2601</fpage><lpage>2610</lpage><pub-id pub-id-type="doi">10.1172/JCI118709</pub-id><pub-id pub-id-type="pmid">8647954</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuhlmann</surname> <given-names>T</given-names></name><name><surname>Planells-Cases</surname> <given-names>R</given-names></name><name><surname>Jentsch</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>LRRC8/VRAC anion channels enhance ß-cell glucose sensing and insulin secretion</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>1974</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-04353-y</pub-id><pub-id pub-id-type="pmid">29773801</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syeda</surname> <given-names>R</given-names></name><name><surname>Qiu</surname> <given-names>Z</given-names></name><name><surname>Dubin</surname> <given-names>AE</given-names></name><name><surname>Murthy</surname> <given-names>SE</given-names></name><name><surname>Florendo</surname> <given-names>MN</given-names></name><name><surname>Mason</surname> <given-names>DE</given-names></name><name><surname>Mathur</surname> <given-names>J</given-names></name><name><surname>Cahalan</surname> <given-names>SM</given-names></name><name><surname>Peters</surname> <given-names>EC</given-names></name><name><surname>Montal</surname> <given-names>M</given-names></name><name><surname>Patapoutian</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>LRRC8 proteins form Volume-Regulated anion channels that sense ionic strength</article-title><source>Cell</source><volume>164</volume><fpage>499</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.12.031</pub-id><pub-id pub-id-type="pmid">26824658</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tack</surname> <given-names>CJ</given-names></name><name><surname>Ong</surname> <given-names>MK</given-names></name><name><surname>Lutterman</surname> <given-names>JA</given-names></name><name><surname>Smits</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone</article-title><source>Diabetologia</source><volume>41</volume><fpage>569</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1007/s001250050948</pub-id><pub-id pub-id-type="pmid">9628275</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trouet</surname> <given-names>D</given-names></name><name><surname>Nilius</surname> <given-names>B</given-names></name><name><surname>Jacobs</surname> <given-names>A</given-names></name><name><surname>Remacle</surname> <given-names>C</given-names></name><name><surname>Droogmans</surname> <given-names>G</given-names></name><name><surname>Eggermont</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Caveolin-1 modulates the activity of the volume-regulated chloride channel</article-title><source>The Journal of Physiology</source><volume>520 Pt 1</volume><fpage>113</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7793.1999.t01-1-00113.x</pub-id><pub-id pub-id-type="pmid">10517805</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trouet</surname> <given-names>D</given-names></name><name><surname>Hermans</surname> <given-names>D</given-names></name><name><surname>Droogmans</surname> <given-names>G</given-names></name><name><surname>Nilius</surname> <given-names>B</given-names></name><name><surname>Eggermont</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Inhibition of volume-regulated anion channels by dominant-negative caveolin-1</article-title><source>Biochemical and Biophysical Research Communications</source><volume>284</volume><fpage>461</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2001.4995</pub-id><pub-id pub-id-type="pmid">11394902</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venema</surname> <given-names>VJ</given-names></name><name><surname>Zou</surname> <given-names>R</given-names></name><name><surname>Ju</surname> <given-names>H</given-names></name><name><surname>Marrero</surname> <given-names>MB</given-names></name><name><surname>Venema</surname> <given-names>RC</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Caveolin-1 detergent solubility and association with endothelial nitric oxide synthase is modulated by tyrosine phosphorylation</article-title><source>Biochemical and Biophysical Research Communications</source><volume>236</volume><fpage>155</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1997.6921</pub-id><pub-id pub-id-type="pmid">9223444</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voss</surname> <given-names>FK</given-names></name><name><surname>Ullrich</surname> <given-names>F</given-names></name><name><surname>Münch</surname> <given-names>J</given-names></name><name><surname>Lazarow</surname> <given-names>K</given-names></name><name><surname>Lutter</surname> <given-names>D</given-names></name><name><surname>Mah</surname> <given-names>N</given-names></name><name><surname>Andrade-Navarro</surname> <given-names>MA</given-names></name><name><surname>von Kries</surname> <given-names>JP</given-names></name><name><surname>Stauber</surname> <given-names>T</given-names></name><name><surname>Jentsch</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Identification of LRRC8 heteromers as an essential component of the volume-regulated anion channel VRAC</article-title><source>Science</source><volume>344</volume><fpage>634</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1126/science.1252826</pub-id><pub-id pub-id-type="pmid">24790029</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>R</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Gunasekar</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Benson</surname> <given-names>CJ</given-names></name><name><surname>Chapleau</surname> <given-names>MW</given-names></name><name><surname>Sah</surname> <given-names>R</given-names></name><name><surname>Abboud</surname> <given-names>FM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The volume-regulated anion channel (LRRC8) in nodose neurons is sensitive to acidic pH</article-title><source>JCI Insight</source><volume>2</volume><elocation-id>e90632</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.90632</pub-id><pub-id pub-id-type="pmid">28289711</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>Wang</surname> <given-names>D</given-names></name><name><surname>Kong</surname> <given-names>C</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Xie</surname> <given-names>L</given-names></name><name><surname>Lin</surname> <given-names>Z</given-names></name><name><surname>Zheng</surname> <given-names>Y</given-names></name><name><surname>Zhou</surname> <given-names>J</given-names></name><name><surname>Han</surname> <given-names>Y</given-names></name><name><surname>Ji</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>eNOS S-nitrosylation mediated OxLDL-induced endothelial dysfunction via increasing the interaction of eNOS with ß-catenin</article-title><source>Biochimica Et Biophysica Acta (BBA) - Molecular Basis of Disease</source><volume>1865</volume><fpage>1793</fpage><lpage>1801</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2018.02.009</pub-id><pub-id pub-id-type="pmid">29471036</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westerbacka</surname> <given-names>J</given-names></name><name><surname>Vehkavaara</surname> <given-names>S</given-names></name><name><surname>Bergholm</surname> <given-names>R</given-names></name><name><surname>Wilkinson</surname> <given-names>I</given-names></name><name><surname>Cockcroft</surname> <given-names>J</given-names></name><name><surname>Yki-Järvinen</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity</article-title><source>Diabetes</source><volume>48</volume><fpage>821</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.2337/diabetes.48.4.821</pub-id><pub-id pub-id-type="pmid">10102699</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname> <given-names>IL</given-names></name><name><surname>Chowienczyk</surname> <given-names>PJ</given-names></name><name><surname>Wheatcroft</surname> <given-names>SB</given-names></name><name><surname>Patel</surname> <given-names>A</given-names></name><name><surname>Sherwood</surname> <given-names>R</given-names></name><name><surname>Momin</surname> <given-names>A</given-names></name><name><surname>Shah</surname> <given-names>AM</given-names></name><name><surname>Kearney</surname> <given-names>MT</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Effect of fat distribution on endothelial-dependent and endothelial-independent vasodilatation in healthy humans</article-title><source>Diabetes, Obesity and Metabolism</source><volume>8</volume><fpage>296</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1111/j.1463-1326.2005.00505.x</pub-id><pub-id pub-id-type="pmid">16634989</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>KK</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Regulation of endothelial nitric oxide synthase activity and gene expression</article-title><source>Annals of the New York Academy of Sciences</source><volume>962</volume><fpage>122</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2002.tb04062.x</pub-id><pub-id pub-id-type="pmid">12076969</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Gunasekar</surname> <given-names>SK</given-names></name><name><surname>Mishra</surname> <given-names>A</given-names></name><name><surname>Cao</surname> <given-names>L</given-names></name><name><surname>Sah</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Induction of adipose and hepatic SWELL1 expression is required for maintaining systemic insulin-sensitivity in obesity</article-title><source>Channels</source><volume>11</volume><fpage>673</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1080/19336950.2017.1373225</pub-id><pub-id pub-id-type="pmid">28873008</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname> <given-names>G</given-names></name><name><surname>Nystrom</surname> <given-names>FH</given-names></name><name><surname>Ravichandran</surname> <given-names>LV</given-names></name><name><surname>Cong</surname> <given-names>LN</given-names></name><name><surname>Kirby</surname> <given-names>M</given-names></name><name><surname>Mostowski</surname> <given-names>H</given-names></name><name><surname>Quon</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Roles for insulin receptor, PI3-kinase, and akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells</article-title><source>Circulation</source><volume>101</volume><fpage>1539</fpage><lpage>1545</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.101.13.1539</pub-id><pub-id pub-id-type="pmid">10747347</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname> <given-names>G</given-names></name><name><surname>Quon</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells</article-title><source>Journal of Clinical Investigation</source><volume>98</volume><fpage>894</fpage><lpage>898</lpage><pub-id pub-id-type="doi">10.1172/JCI118871</pub-id><pub-id pub-id-type="pmid">8770859</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>DX</given-names></name><name><surname>Mendoza</surname> <given-names>SA</given-names></name><name><surname>Bubolz</surname> <given-names>AH</given-names></name><name><surname>Mizuno</surname> <given-names>A</given-names></name><name><surname>Ge</surname> <given-names>ZD</given-names></name><name><surname>Li</surname> <given-names>R</given-names></name><name><surname>Warltier</surname> <given-names>DC</given-names></name><name><surname>Suzuki</surname> <given-names>M</given-names></name><name><surname>Gutterman</surname> <given-names>DD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Transient receptor potential vanilloid type 4-deficient mice exhibit impaired endothelium-dependent relaxation induced by acetylcholine in vitro and in vivo</article-title><source>Hypertension</source><volume>53</volume><fpage>532</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.108.127100</pub-id><pub-id pub-id-type="pmid">19188524</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Xie</surname> <given-names>L</given-names></name><name><surname>Gunasekar</surname> <given-names>SK</given-names></name><name><surname>Tong</surname> <given-names>D</given-names></name><name><surname>Mishra</surname> <given-names>A</given-names></name><name><surname>Gibson</surname> <given-names>WJ</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Fidler</surname> <given-names>T</given-names></name><name><surname>Marthaler</surname> <given-names>B</given-names></name><name><surname>Klingelhutz</surname> <given-names>A</given-names></name><name><surname>Abel</surname> <given-names>ED</given-names></name><name><surname>Samuel</surname> <given-names>I</given-names></name><name><surname>Smith</surname> <given-names>JK</given-names></name><name><surname>Cao</surname> <given-names>L</given-names></name><name><surname>Sah</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>504</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1038/ncb3514</pub-id><pub-id pub-id-type="pmid">28436964</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>Ha</surname> <given-names>CH</given-names></name><name><surname>Kim</surname> <given-names>JY</given-names></name><name><surname>Wong</surname> <given-names>C</given-names></name><name><surname>Redmond</surname> <given-names>EM</given-names></name><name><surname>Hamik</surname> <given-names>A</given-names></name><name><surname>Jain</surname> <given-names>MK</given-names></name><name><surname>Feng</surname> <given-names>GS</given-names></name><name><surname>Jin</surname> <given-names>ZG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Endothelial Grb2-associated binder 1 is crucial for postnatal angiogenesis</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>31</volume><fpage>1016</fpage><lpage>1023</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.111.224493</pub-id><pub-id pub-id-type="pmid">21372298</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.61313.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Nelson</surname><given-names>Mark T</given-names></name><role>Reviewing Editor</role><aff><institution>University of Vermont</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Nelson</surname><given-names>Mark T</given-names></name><role>Reviewer</role><aff><institution>University of Vermont</institution><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Sukumar</surname><given-names>Piruthivi</given-names> </name><role>Reviewer</role><aff><institution/></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>In their manuscript, Alghanem et al. provide the first demonstration that LRRC8a (leucine rich repeat-containing protein 8a), also known as SWELL1, encodes the endothelial volume regulatory anion channel (VRAC). Using a human umbilical vein endothelial cell (HUVEC) model and an RNA interference (RNAi) approach, they also show that SWELL1 knockdown in vitro suppresses AKT-eNOS signaling while enhancing mTOR signaling, suggesting that SWELL1 normally positively regulates the AKT-eNOS pathway and negatively regulates mTOR signaling.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;The SWELL1-LRRC8 complex regulates endothelial AKT-eNOS-mTOR signaling and vascular function&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, including Mark T Nelson as the (Reviewing Editor and Reviewer #1), and the evaluation has been overseen by Kenton Swartz as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Piruthivi Sukumar (Reviewer #3).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in <italic>eLife</italic> but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.</p><p>Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in <italic>eLife</italic>, either of which would be linked to the original paper.</p><p>Summary:</p><p>In their manuscript, Alghanem et al. provide the first demonstration that LRRC8a (leucine rich repeat-containing protein 8a), also known as SWELL1, encodes the endothelial volume regulatory anion channel (VRAC). Using a human umbilical vein endothelial cell (HUVEC) model and an RNA interference (RNAi) approach, they also show that SWELL1 knockdown in vitro suppresses AKT-eNOS signaling while enhancing mTOR signaling, suggesting that SWELL1 normally positively regulates the AKT-eNOS pathway and negatively regulates mTOR signaling. Consistent with previous results obtained in adipocytes, they also found that endothelial SWELL1 forms a signaling complex with GRB2, Cav1 and eNOS, and further showed that this SWELL1-GRB2-Cav1-eNOS complex mediates stretch-induced activation of PI3K-AKT-eNOS signaling. in vivo studies in endothelial-specific Swell1-knockdown mice confirmed that SWELL1 mediates hypotonically activated currents in native endothelial cells and also negatively regulates endothelial cell migration and angiogenesis, as evidenced by an increase in ex vivo sprouting angiogenesis from aortic explants from mice lacking endothelial SWELL1. Consistent with this, genome-wide transcriptome analyses showed enrichment for genes/pathways involved in regulating angiogenesis, migration and tumorigenesis, including GADD45, IL-8, p70S6K (mTOR), TREM1, angiopoeitin and HGF, in SWELL1-KD HUVECs. Knockdown of SWELL1 in HUVECs also increased expression of VEGFA and CD31, both of which are pro-angiogenic and are associated with mTORC1 hyperactivation. Finally, given previous reports of SWELL1 involvement in insulin signaling (via PI3K-AKT) in adipocytes and overrepresentation of pathways (e.g., cell adhesion, renin-angiotensin signaling) in SWELL1-KD HUVECs that are altered in the vasculature in the context of atherosclerosis and type 2 diabetes (T2D), they investigated the effects of SWELL1 knockdown in a hypertensive (angiotensin II infusion) and T2D (high-fat high-sucrose diet) setting, demonstrating exacerbated systolic hypertension and impaired retinal blood flow in male SWELL1-KD mice.</p><p>Revisions for this paper:</p><p>1) The authors should respond to concerns with careful editing of the manuscript and refrain from conclusions not fully supported by the current data, such as &quot;SWELL1 regulates AKT-eNOS signaling via SWELL1-GRB2-Cav1 signaling complex&quot;, &quot;SWELL1 negatively regulates mTOR signaling&quot;. In addition, just like hypotonicity-activated TRPV4, whether VRAC is mechanosensitive is also subject to debate.</p><p>2) The evidence for the interaction of SWELL1 with Grb2, Cav1 and eNOS does not necessarily reveal the underlying mechanism(s) for how SWELL1 regulates the basal eNOS expression and AKT-eNOS signaling. What might activate/regulate SWELL1 at the basal condition? Do the effects require the SWELL1 channel activity? If yes, how the channel conduction regulates Grb2 signaling? If not, how the protein-protein interaction itself regulates Grb2 signaling. Knocking down SWELL1 did not reduce the interaction between Grb2 and Cav1 (Figure 3A). So presumably, SWELL1 is not required for the protein complex formation per se. The data presented does not address the mechanism on how SWELL1 regulates eNOS expression and the basal AKT-eNOS signaling.</p><p>3) Fluid shear stress is a more relevant force experienced by endothelium. It's well-established that shear stress stimulates many folds increase in phosphorylation of AKT and eNOS in HUVEC. It's one of the hallmarks of endothelial mechanosensitivity. However, the authors performed experiments by stretching HUVEC cells and accordingly observed very poor AKT-eNOS response. Thus, shear stress might be a more appropriate system to test the potential role of SWELL1 in endothelium mechanotransduction. It's still very unclear whether SWELL1 is indeed a mechanosensitive channel. Is endothelial SWELL1 channel activated by shear stress and/or stretch? How does the channel activation lead to downstream changes in AKT-eNOS signaling, by changes in membrane potential, secondary massager, or changes in Grb2-Cav1-eNOS complexes?</p><p>4) The authors suggested that SWELL1 regulates AKT-eNOS, NO production, and thus play a role in vasodilation, which may explain the KO mouse phenotype, such as hypertension and retinal microvascular disease in the setting of Type 2 diabetes. A more detailed biochemical and cell biological characterization of eSWELL1 KO mice is warranted to bridge the data in HUVEC with the mouse model. For example, it's well-establish that flow induces vasodilation of mesenteric arteries ex vivo. Do eSWELL1 KO arteries exhibit a flow-induced vasodilation defect? Does the dramatic downregulation of eNOS expression exist in KO mice? Does the flow-induced NO release is impaired in KO endothelium?</p><p>5) Total eNOS and AKT level changes are interesting and which are neither explored experimentally nor discussed. Authors have to comment on the potential mechanism/significance of that with respect to phenotypic observations.</p><p>6) Is SWELL1 constitutively active? How do the authors explain the &quot;basal&quot; (without stretch) effects of SWELL1 KD?</p><p>7) Both chow/HFHS model animals with SWELL1 KO were not phenotyped completely. At least basal characteristics such as weight, activity etc should be reported to rule out the &quot;metabolic&quot; causes for observed vascular effects. It is especially important since the ITT/GTT were done after 10 months- an advanced/old stage in which it is hard to see differences in ITT/GTT.</p><p>8) mTOR pathway is too underdeveloped to make any claim in the Abstract; I think it is mere observation which could be due to &quot;unknown&quot; signalling outside of what is described in the manuscript.</p><p>9) Explant assay data presented in Figure 5 is distracting as it does not fit with eNOS story; Expectedly the SWELL1 signalling is more complex than reported- both pro and anti angiogenic. But unless it is explored bit deeper, it won't add anything to the manuscript.</p><p>10) Finally, there is another mechanically activated channel in EC- Piezo1. What was its' level in KO cells (RNA seq data)? Some discussion on that will be useful for the readers.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.61313.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Revisions for this paper:</p><p>1) The authors should respond to concerns with careful editing of the manuscript and refrain from conclusions not fully supported by the current data, such as &quot;SWELL1 regulates AKT-eNOS signaling via SWELL1-GRB2-Cav1 signaling complex&quot;, &quot;SWELL1 negatively regulates mTOR signaling&quot;. In addition, just like hypotonicity-activated TRPV4, whether VRAC is mechanosensitive is also subject to debate.</p></disp-quote><p>We agree with these comments and thank the reviewers for pointing this out. We have edited the manuscript as described above.</p><disp-quote content-type="editor-comment"><p>2) The evidence for the interaction of SWELL1 with Grb2, Cav1 and eNOS does not necessarily reveal the underlying mechanism(s) for how SWELL1 regulates the basal eNOS expression and AKT-eNOS signaling. What might activate/regulate SWELL1 at the basal condition? Do the effects require the SWELL1 channel activity? If yes, how the channel conduction regulates Grb2 signaling? If not, how the protein-protein interaction itself regulates Grb2 signaling. Knocking down SWELL1 did not reduce the interaction between Grb2 and Cav1 (Figure 3A). So presumably, SWELL1 is not required for the protein complex formation per se. The data presented does not address the mechanism on how SWELL1 regulates eNOS expression and the basal AKT-eNOS signaling.</p></disp-quote><p>We agree that we have not delineated the detailed molecular mechanism that underlies how SWELL1 regulates basal eNOS expression, nor how it regulates eNOS phosphorylation (p-eNOS). In this paper, we merely demonstrate that SWELL1 forms a complex with GRB2, Cav1 and eNOS, demonstrate that SWELL1 depletion impairs pAKT and peNOS, and then hypothesize (now added in the Discussion) that these signaling effects occur via protein-protein interactions between SWELL1, GRB2, Cav1 and eNOS – similar to our previously proposed working model for SWELL1-GRB2-AKT2 signaling in adipocytes (Zhang et al., 2017 and Gunasekar et al., 2019). We also propose an alternative mechanism that considers SWELL1 channel mediated effects in endothelial cell membrane and calcium influx via other mechanosensitive (Piezo1) or mechanoresponsive (TRPV4) – also added to the Discussion section. Delineating these detailed molecular mechanisms will be the subject of future manuscripts.</p><disp-quote content-type="editor-comment"><p>3) Fluid shear stress is a more relevant force experienced by endothelium. It's well-established that shear stress stimulates many folds increase in phosphorylation of AKT and eNOS in HUVEC. It's one of the hallmarks of endothelial mechanosensitivity. However, the authors performed experiments by stretching HUVEC cells and accordingly observed very poor AKT-eNOS response. Thus, shear stress might be a more appropriate system to test the potential role of SWELL1 in endothelium mechanotransduction.</p></disp-quote><p>The vascular endothelium is exposed to a variety of mechanical forces, including laminar, continuous, turbulent and pulsatile shear flow, in addition to stretching forces that occur during arterial pressure waves with each heartbeat. Indeed, there are dozens of papers that have studied the response of endothelial cells to axial stretch (Reviewed in Jufri et al., 2015) as we have, so it remains, in our opinion, a relevant mechanical stimulus to study. However, we agree that shear flow is also a relevant stimulus to examine in HUVECs upon SWELL1 depletion. Accordingly, we have included a new experiment, shown in new Figure 5 and new Figure 5—videos 1-4, wherein we discover that the ability of HUVECs to align along the direction of laminar shear flow is markedly impaired in SWELL1 KD cells – suggesting that these cells have either impaired ability to sense, or to respond to laminar shear flow (or both). Associated with this is a reduction in p-eNOS induction (assessed by IF staining) in response shear flow in SWELL1 depleted HUVECs. These data are consistent with the p-eNOS results observed under basal conditions, and in response to axial stretch. The shear flow system available to us for these studies was limited in the number of cells that could be plated, and thus we were unable to perform Western blots to assess for shear-flow mediated signaling as we could perform with the FlexCell system, despite weeks of effort. It is for this reason that we resorted to quantification of peNOS by immunofluorescence staining – which is feasible with a much smaller number of cells. Regardless, we thank the reviewer for raising this question as it allowed us to uncover a cellular phenotype that we would not have otherwise observed, and also motivated us to explore another physiologically relevant form of mechanical stimulation.</p><disp-quote content-type="editor-comment"><p>It's still very unclear whether SWELL1 is indeed a mechanosensitive channel. Is endothelial SWELL1 channel activated by shear stress and/or stretch? How does the channel activation lead to downstream changes in AKT-eNOS signaling, by changes in membrane potential, secondary massager, or changes in Grb2-Cav1-eNOS complexes?</p></disp-quote><p>These are both very good questions. We have not answered these specific questions in this manuscript, but they remain questions for the next paper, or for a Research Advance, as we are currently developing methods to measure endothelial SWELL1 channel activation in response to shear flow. The hypotheses addressing the second question of how “channel activation leads to downstream changes in AKT-eNOS signaling, by changes in membrane potential, secondary massager, or changes in Grb2-Cav1-eNOS complexes” are also now addressed in the Discussion.</p><disp-quote content-type="editor-comment"><p>4) The authors suggested that SWELL1 regulates AKT-eNOS, NO production, and thus play a role in vasodilation, which may explain the KO mouse phenotype, such as hypertension and retinal microvascular disease in the setting of Type 2 diabetes. A more detailed biochemical and cell biological characterization of eSWELL1 KO mice is warranted to bridge the data in HUVEC with the mouse model. For example, it's well-establish that flow induces vasodilation of mesenteric arteries ex vivo. Do eSWELL1 KO arteries exhibit a flow-induced vasodilation defect? Does the dramatic downregulation of eNOS expression exist in KO mice? Does the flow-induced NO release is impaired in KO endothelium?</p></disp-quote><p>As mentioned in the introductory paragraph above, new experiments in the eSWELL1 KO mouse were not possible during these past few months due to a temporary lack of availability of this mouse model, arising from the impact of COVID19. Accordingly, we have addressed these comments “to bridge the data in HUVEC with the mouse model” by using tissue samples that were previously collected from these mice. Specifically, we performed immunofluorescence staining for p-eNOS in endothelium from aortas harvested from WT and eSWELL1 KO mice (Figure 7H and I), and found this to be diminished as well, similar to SWELL1 KD HUVECs. Again, once a colony of WT and eSWELL1 KO mice again become available, we will examine flow-mediated vasodilation and other measures of flow-induced NO release in vascular endothelium.</p><disp-quote content-type="editor-comment"><p>5) Total eNOS and AKT level changes are interesting and which are neither explored experimentally nor discussed. Authors have to comment on the potential mechanism/significance of that with respect to phenotypic observations.</p></disp-quote><p>We agree that these changes in eNOS expression are interesting and warrant further exploration. We can only speculate that SWELL1 is somehow regulating eNOS gene expression. Given that NF-kappaB is thought to regulate eNOS expression in endothelium we hypothesize that this pathway may be implicated. Moreover, both PI3K and ERK1/2 signaling pathways have been described to regulate total eNOS expression (Reviewed in Wu et al., 2002), and we observe reductions in both PI3K and ERK1/2 signaling in SWELL1 KD HUVECs, so reductions in eNOS expression are certainly consistent with disruptions in these signaling pathways. Indeed, consistent with this conserved biology with respect to SWELL1 signaling, we also observed significant 2-fold reductions in AKT2 expression upon SWELL1 deletion in both 3T3-F442A adipocytes and in C2C12 myotubes, in addition to reductions in NOS2 (iNOS) in adipocytes and NOS1 (neuronal NOS) in C2C12. Collectively, these findings across multiple cell types support a PI3K and ERK1/2 mediated mechanism of regulation of eNOS and AKT2 gene expression. These mechanisms are now discussed in the Discussion.</p><disp-quote content-type="editor-comment"><p>6) Is SWELL1 constitutively active? How do the authors explain the &quot;basal&quot; (without stretch) effects of SWELL1 KD?</p></disp-quote><p>We do believe that SWELL1 has constitutive activity, via protein-protein signaling, by restraining GRB2 inhibition of the PI3K-AKT-MAPK pathway, or by conductive, channel mediated mechanisms that are yet to be explored. Indeed, others have made measurement of basal, or constitutive VRAC activity in neurons (Zhang, H., et al., PLoS ONE 2011; Inoue, H., et al., J. Neurosci 2007) and ß cells (Best, L. et al. Pflug. Arch. 2002) and estimate it at NP = ~0.06, at 1 mM glucose in ß cells.</p><disp-quote content-type="editor-comment"><p>7) Both chow/HFHS model animals with SWELL1 KO were not phenotyped completely. At least basal characteristics such as weight, activity etc should be reported to rule out the &quot;metabolic&quot; causes for observed vascular effects. It is especially important since the ITT/GTT were done after 10 months- an advanced/old stage in which it is hard to see differences in ITT/GTT.</p></disp-quote><p>We now include additional metabolic phenotyping data of the WT and eSWELL1 KO mice raised on HFHS diet, including body weight, fat mass, lean mass, % fat mass and % lean mass in Figure 8—figure supplement 4 to complement the GTT and ITT data provided in the first submission. These data reveal a difference in body weight that is driven by increased adiposity in female but not male mice. However, the significant differences in retinal vessel blood flow in female mice are observed in the absence of measurable differences in glycemic control or systemic insulin sensitivity.</p><disp-quote content-type="editor-comment"><p>8) mTOR pathway is too underdeveloped to make any claim in the Abstract; I think it is mere observation which could be due to &quot;unknown&quot; signalling outside of what is described in the manuscript.</p></disp-quote><p>We agree completely with this comment and have accordingly removed this from the Abstract and primarily describe the mTOR pathway findings as a curious observation.</p><disp-quote content-type="editor-comment"><p>9) Explant assay data presented in Figure 5 is distracting as it does not fit with eNOS story; Expectedly the SWELL1 signalling is more complex than reported- both pro and anti angiogenic. But unless it is explored bit deeper, it won't add anything to the manuscript.</p></disp-quote><p>We agree and appreciate this feedback in helping us streamline the message of this manuscript. Accordingly, we have removed the explant data analysis from the manuscript, but have left in quantification of SWELL1 immunostaining of WT compared to eSWELL1 KO endothelial tubes, since these data provide validation of the endothelial targeted SWELL1 KO mouse (in addition to the patch-clamp data from WT and SWELL1 KO primary endothelial cells shown in Figure 7A-E).</p><disp-quote content-type="editor-comment"><p>10) Finally, there is another mechanically activated channel in EC- Piezo1. What was its' level in KO cells (RNA seq data)? Some discussion on that will be useful for the readers.</p></disp-quote><p>Indeed, EC-Piezo1 is a very important mechanically activated ion channel to discuss. In response to this comment, we now formally plot the Piezo1 mRNA levels in HUVEC (+/- SWELL1) obtained from our RNA sequencing experiments (as well at TRPV4, another very relevant mechanoresponsive ion channel expressed in endothelium), and compare this to SWELL1 mRNA expression and other LRRC8 proteins in new Figure 6C. We also add some discussion in the Results and Discussion.</p></body></sub-article></article>